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1 Abstract 
In eukaryotes, chromatin is a highly dynamic and well organized nucleoprotein complex of 
DNA and histones that influences several important biological processes such as DNA 
replication, transcription and repair. The fundamental unit of chromatin is the nucleosome 
consisting of 147 bp of DNA wrapped around an octamer of four histone proteins: H3, H4, 
H2A and H2B. The structure of nucleosome and chromatin fibres can be modulated in various 
ways in response to specific biological signals. Together with the presence of specific histone 
modifications, histone variants are key players in modulating the nucleosome stability and 
accessibility; thus influencing the overall chromatin structure. 
Two particular histone variants, H2A.Bbd and macroH2A.1.2 have been extensively studied 
in recent years due to their influence on the nucleosome structure and their role in 
transcription regulation. However not so much is known about the proteomic profile of the 
chromatin domains that contain H2A.Bbd and macroH2A.1.2. 
This PhD project provides a comprehensive analysis of the proteins associated to specific 
chromatin domains containing the histone variants H2A.Bbd and macroH2A.1.2. Based on 
the proteomic analysis, it has been found that macroH2A.1.2 is enriched in heterochromatic 
factors such as the Polycomb Repressive Complexes 1 and 2 (PRC2 and PRC1) and the 
methyltransferase Suv39h1, whereas H2A.Bbd is mainly present at active chromatin marked 
by factors involved in splicing and DNA replication.  
Moreover, the combination of mass spectrometry and immunofluorescence-based approaches 
revealed that H2A.Bbd is recruited at sites of DNA synthesis during replication and DNA 
repair. Interestingly, the cells that overexpress this histone variant show faster replication and 
higher sensitivity to DNA damage. Furthermore, this study shows for the first time that 
Hodgkin’s Lymphoma (HL) cell lines abnormally express H2A.Bbd and that the expression 
levels of this histone variant inversely correlate with the HL doubling time.  
In summary, this study describes the protein composition of the chromatin containing the 
histone variants H2A.Bbd and macroH2A.1.2 and reveals new, interesting features of 
H2A.Bbd and its role in spermatogenesis and cancer. 
  2 
2 Introduction 
2.1 Chromatin 
The word ‘Chromatin’ was first used by Flemming at the end of the 19th century to 
differentiate between a stainable material present in the nuclei and a non-stainable material 
that he defined as ‘chromatin’ (Flemming, 1882). 
Shortly after, at the beginning of the 20th century Heitz observed that various chromatin 
regions behaved differently during cell replication, already suggesting that chromatin is not 
uniform in structure. Due to their different staining behavior he defined those regions as 
‘euchromatin’ and ‘heterochromatin’. After more than one century from its first description, 
progresses have been made in understanding chromatin structure and regulation. It has 
become more and more apparent that chromatin is a dynamic complex of DNA wound around 
basic histone proteins, and that the higher order chromatin structure greatly influences gene 
regulation. The classification of chromatin types has developed into a much more complex 
system than the simple euchromatin- heterochromatin dichotomy, resulting in a color code 
scheme where chromatin is defined by at least five different classes according to its protein 
composition (Filion et al., 2010). Chromatin is a highly dynamic structure regulated by 
several features such as specific histone variants and/or histone modifications. These two 
specific chromatin features alter the intra- and inter-nucleosomal interactions and recruit 
specific protein factors that, consequently, modulate gene expression and transcription. 
 
2.2 The Nucleosome 
The first evidence that the DNA is present in the nucleus in particles and wound around a 
histone protein core was found in the early 1970’s (Noll, 1974; Van Holde et al., 1974). 
During 1974-75 the nucleosome was characterized and defined as the fundamental chromatin 
unit. It has been shown that the chromatin of various species can be digested by different 
endonucleases giving rise to fragments of approximately 200 bp and that histone H3 and H4 
form the core of these particles (Hewish and Burgoyne, 1973; Kornberg, 1974; Kornberg and 
Thomas, 1974). 
Histone proteins can be classified in core histones (H3, H4, H2A and H2B) and linker 
histones (H1 family). It was not until 1997 that the atomic structure of the nucleosome was 
resolved at a resolution of 2.8 Å (Figure 2.1).  
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Figure 2.1 Nucleosome core particle structure published by Karolin Luger in 1997. 
Two different views of the nucleosome particle taken from down the DNA superhelix (left) and perpendicular to 
it (right). The eight histones proteins forming the octamer are visible: blu-H3; green-H4; yellow-H2A; red-H2B 
(Figure taken from (Luger et al., 1997). 
 
The nucleosome structure revealed that 146 bp of DNA are wrapped around the histone 
octamer in 1.65 turns of a flat, left handed superhelix. The central core histone fold domains 
maintained a high structural similarity during evolution due to their important role in the 
nucleosome structure. They are formed by three α-helices connected by two loops: L1 and L2.  
The histone octamer is formed by a tetramer of H3-H4 (H3-H4)2 and two dimers of H2A-
H2B. H3 and H4 form the tetramer via the interaction between H3 and H3’ through a 4-helix 
bundle (4-HB). The interaction of the H2A and H2B pair with the tetramer takes place 
through a second homologous 4-helix bundle between H2A and H4. The C-terminal docking 
domain of the histone H2A directs the interaction of the nucleosome with the DNA and it is 
important for nucleosome stability. These interactions also involve the N-terminal tail of H3 
(Luger et al., 1997). 
 
In addition to the core domains every histone contains N-terminal or C-terminal extensions. 
The histone N-terminal tail protrudes away from the histone octamer structure. In contrast to 
the histone core domains, the N-terminal histone tails are unstructured and not visible in any 
of the crystal structures elaborated so far. Nevertheless, the histone tails sequences are highly 
conserved among species, implying an important role in the regulation of the nucleosome 
function and the organization of the higher order chromatin structure. 
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2.3 Higher order chromatin structure 
How chromatin is organized in the nucleus in higher ordered structure is still widely debated. 
The major difficulty scientists encountered in the past was the absence of an experimental 
tool that allowed for the study of chromatin structure in the presence of an intact nucleus. For 
this reason all the models obtained so far are based on in vitro experiments where chromatin 
is assembled and folded, or only folded, outside its natural context. 
What is known is that the nucleosome compaction into chromatin structures requires the inter-
nucleosomes interactions that involve both the core histone tails and their modifications. The 
inter-nucleosome interactions promote the formation of the 30 nm fibres from an 11 nm 
nucleosome array (the beads on a string) (Figure 2.2). 
 
 
Figure 2.2 Higher order chromatin structure. 
The primary structure of chromatin is represented as a nucleosomal array composed either by nucleosome 
containing the canonical histones (light grey), or nucleosome containing particular histone variants (light blue). 
In addition, the primary structure is marked by specific histone modifications (green and red flags). The 
nucleosome-nucleosome interactions form a folded chromatin fibre (secondary structure). The interactions 
between chromatin fibres result in the higher order chromatin structure (tertiary structure). Secondary and 
tertiary chromatin structure are stabilized by architectural proteins (purple ellipse). Double arrows indicate the 
transitions between different structural levels. These transitions can be regulated by changes in the histone 
modification profiles, by the histone exchange and by the displacement of the architectural proteins (Figure 
adapted after (Luger et al., 2012)). 
 
The studies that used Electron Microscopy (EM) performed on chromatin isolated from nuclei, 
suggested two models for the 30 nm fibre. The first one, the ‘solenoid’ or the ‘one-start helix’ 
model, has 6-8 nucleosomes per turn with adjacent nucleosomes connected by a bent linker 
DNA (Robinson et al., 2006). The second model proposes two rows of interdigitated 
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nucleosomes resulting in a two-start helix, which is stabilized by the interaction of alternate 
nucleosomes. In this model the nucleosomes are connected by straight linker DNA (Dorigo, 
2004; Schalch et al., 2005). 
 
The use of chromatin isolated from nuclei has the advantage that it most likely resembles the 
native state of chromatin. However, it is also very heterogeneous with regards to DNA 
sequence, histone modifications and nucleosome spacing. A good alternative to the native 
chromatin is the use of homogenous DNA carrying a well-characterized nucleosome 
positioning sequence for in vitro reconstitution of chromatin. With the 601-sequence it was 
possible to reduce in part the native chromatin complexity, however the structures obtained 
from these experiments were still largely depending on the experimental conditions. Indeed, 
when the 601-sequence was used and EM performed on the crystal structure of a 
tetranucleosome core array lacking the linker histone, a two start crossed-linker model for the 
30 nm fibre was proposed (Dorigo, 2004; Schalch et al., 2005). However, the crystallized 
tetranucleosome had a nucleosomal repeat length (NRL) of only 167 bp, which is shorter than 
the typical 200 bp found in most of the eukaryotic organisms. In addition, the concentration of 
divalent cation Mg2+used for the experiments is not common in nature. The use of a longer 
array (177 to 237 bp), the inclusion of the linker histone and lower divalent cation Mg2+ 
concentration, revealed a one-start interdigitated solenoid structure (Robinson and Rhodes, 
2006). Further experiments revealed that the nucleosome repeat length (NRL) and the linker 
histone play an important role in the chromatin folding (Robinson and Rhodes, 2006). 
However, the biological role of the linker histone H1 in the higher order chromatin structure 
is still under debate (Fan et al., 2005). 
 
A recent study using Electron Microscopy-Assisted Nucleosome Capture (EMANIC) in in 
vitro assembled chromatin showed that chromatin might be rather heteromorphic with 
different types of fibres organization. Indeed, even if the fibres showed predominantly a two-
start organization, the structures also contained bend linker DNA typical of the one-start 
solenoid (Grigoryev et al., 2009). 
As previously mentioned, the methods used so far to study the chromatin structure did not 
allow for its visualization within the nucleus. This problem was recently solved through the 
use of a combination of Electron Spectroscopic Imaging (ESI) and electron tomography. 
Surprisingly, the only regular chromatin structure observed in eukaryotic cell nuclei using this 
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method was the 10 nm fibre. The 10 nm fibre is present at both euchromatic and 
heterochromatic regions where the level of compaction is higher (Fussner et al., 2012). 
 
Beyond the formation of the 30 nm fibre there are a series of long-range interactions that 
promote the formation of the chromatin tertiary structure (Figure 2.2). These long-range 
interactions, or chromatin loops, have been extensively analyzed thanks to the development 
and improvement of new techniques such as Fluorescence in situ Hybridization (FISH) or 
Chromosome Conformation Capture (3C) and Hi-C. In this context, regulatory elements such 
as promoters, enhancers and terminators play an important structural role. Several proteins 
have also been identified to contribute to the formation of chromatin loops between enhancers 
and promoters or promoters and terminators. 
The higher-order chromatin structure plays a central role in gene regulation and transcription. 
In the nucleus, chromatin shows different levels of compaction leading to the formation of 
particular chromatin domains, which differ in protein composition, histone modifications, 
DNA methylation and histone variants.  
2.4 Chromatin domains 
In the nucleus, chromatin is organized into domains that share common features such as the 
same pattern of histone modifications or the presence of specific chromatin binding factors. 
One interesting example of chromatin domains is the Lamina-Associated-Domains (LAD). 
These are large chromatin domains, identified using EM, that are connected to the nuclear 
lamina and that share common epigenetic feature. In human fibroblasts the majority of the 
genes present in the LADs is transcriptionally inactive or shows a low expression level. The 
histone modification H3K27me3 was found to be enriched on the LADs whereas H3K4 
dimethylation is rather low at most promoters of the LADs (Guelen et al., 2008). On the other 
hand, there are large domains associated with the nuclear pore that are actively transcribed 
(Sood and Brickner, 2014). 
 
Due to the presence of specific chromatin binding proteins, a new classification for different 
‘chromatin types’ was recently suggested in Drosophila melanogaster. The five chromatin 
types were defined using a color code system, with a different color for each category. 
GREEN and BLUE chromatin correspond to the heterochromatin protein 1 (HP1) and the 
Polycomb group (PcG) binding domains respectively. Together with these well-characterized 
domains the authors identified the BLACK chromatin, with no transcriptional activity 
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detected, and the RED and YELLOW chromatin as two distinct types of euchromatin. The 
euchromatic domains share several chromatin-binding factors, but they differ in the time of 
replication, with the RED chromatin replicating earlier than the YELLOW, and the marking 
of different genes categories (Filion et al., 2010). A more recent classification in Drosophila 
melanogaster obtained by the Encyclopedia of DNA Elements (modENCODE) that 
integrated multiple data types such as histone modifications, chromatin accessibility, short 
RNAs, non-histone proteins and transcriptional activity, resulted in the identification of 9-
state of chromatin (Kharchenko et al., 2011). 
 
There are rare cases in which entire chromosomes are defined by the presence of specific 
marks that repress or activate their gene expression. This phenomenon happens in the dosage 
compensation process when transcription from one sex chromosome needs to be either hyper-
activated in the heterogametic sex or repressed in the homogametic to balance gene dosage 
between the two sexes. In mammals, for example, one of the two X chromosomes is 
randomly inactivated during female development. The inactive X chromosome is 
characterized by specific epigenetics repressive marks such as H3K27me3, by the presence of 
the Polycomb Repressive Complexes 1 and 2 (PRC2 and PRC1), and the ubiquitination of the 
histone H2A. The maintenance of the repressive state involves the replacement of the histone 
H2A by the histone variant macroH2A (Brockdorff, 2011). 
Together with the histone modifications, the histone variants play a crucial role in regulating 
the gene expression and the structure of specific chromatin domains. This point will be 
discussed in details below. 
 
2.5 Histone modifications 
One system in which the cell modulates nucleosome mobility and turnover is via chemical 
modification of histones. Histone modifications are important in every cellular process where 
DNA access is fundamental i.e. replication, transcription and repair. Ever since the acetylation 
of histones was associated with transcription activation, the interest in histone modifications 
increased enormously, leading to the discovery of over 100 distinct histone modifications 
(Dai et al., 2014). All histones can be modified and most of the modifications occur on the 
histone tails. Among those, two very important and well-characterized modifications are the 
histone acetylation and methylation (Figure 2.3). Others have only been recently discovered 
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and their putative function in cellular processes is still largely unknown (Dai et al., 2014; Tan 
et al., 2011). 
 
 
Figure 2.3 Schematic representation of the histone tail methylation and acetylation. 
Histone tails are subjected to several post-translational modifications. Two very well characterized modifications 
are histone methylation and histone acetylation (green and pink circles respectively). By altering the nucleosome 
structure or by recruiting specific chromatin binding factors, histone methylation and histone acetylation are 
fundamental for the higher order chromatin structure and for gene expression regulation (Figure adapted after 
(Marks et al., 2001)). 
 
The first modification discovered in 1961 was histone acetylation and its function was rapidly 
linked to the gene activation (Allfrey et al., 1964; Pogo et al., 1966). The chemistry of histone 
acetylation easily explains how this modification could facilitate gene activation. Indeed, the 
positive charge of lysine residues is neutralized by the acetylation of histones, thus weakening 
the interactions between the DNA and the nucleosomal histones. This results in an increased 
accessibility of the DNA to the transcription machinery. Even though acetylation has always 
been associated with transcription, recent studies show that this modification plays an 
important role also in replication and DNA repair. This suggests that histone acetylation is 
important in every process that requires relaxation of the DNA-histone contacts 
(Unnikrishnan et al., 2010; Xu and Price, 2011). The lysine residues are acetylated by lysine 
acetyltransferases (HAT) and the acetyl groups are removed by lysine deacetylases (HDAC). 
A specific protein domain recognizes the acetylated residues: the bromodomain (Tamkun et 
al., 1992). The bromodomain is found in a broad range of chromatin-associated factors that 
include the lysine acetyltransferases and also chromatin remodeling factors (Zeng and Zhou, 
2002). 
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A well-known modification, together with the lysine acetylation, is the histone lysine 
methylation. In general, methylation does not alter the positive charge of the lysine. For this 
reason, the effect of methylation on nucleosome stability is considered less active than the 
effect of lysine acetylation. Histone methylation can occur on lysines or arginines, but so far 
the effect of arginine methylation on the nucleosome dynamics remains largely unclear 
(Bedford and Clarke, 2009). Interestingly, the histone lysine can be unmodified or gain a 
mono-, di-, or trimethylated state. However, it is still not clear what influences the 
methylation state of a given lysine residues. Most likely the accessibility and the exposure 
duration of a specific residue to its modifying enzyme play an important role in defining the 
lysine methylation state. Even more interesting is the methylation effect on transcription 
regulation. Different from lysine acetylation, whose role is mostly related to transcription 
activation, lysine methylation can be associated to transcription repression and activation. 
Modifications associated with transcription activation are for example H3K4me3 and 
H3K36me, whereas methylated residues associated with repression are the lysine 9 (K9) and 
lysine 27 (K27) on histone H3 (Zentner and Henikoff, 2013).  
Even though many modifications have been discovered and characterized, new ones are still 
emerging. It has been proposed that histone modifications may work singly or in combination 
thus forming a ‘histone code’, which could define different expression pattern (Rothbart and 
Strahl, 2014). 
 
2.6 Histone variants 
Histone variants are non-allelic isoforms of canonical histones that differ in primary sequence 
and expression timing.  
While canonical histones are mainly expressed during S-phase, histone variants are 
transcribed throughout the cell cycle, replacing the canonical histone in a replication-
independent way (Wu and Bonner, 1981). 
Canonical histones and histone variants differ not only in their time of expression but also in 
their sequence and, interestingly, in structural characteristics of their mRNA. The canonical 
histone genes do not contain introns and their mRNA is not polyadenylated but terminates 
with a stem-loop structure, which is important for the cell cycle regulation of the canonical 
histones (Busslinger et al., 1979; Kedes et al., 1975a; 1975b; Lüscher et al., 1985). In contrast, 
histone variants genes encode for longer polyadenylated mRNA containing introns (Brush et 
al., 1985; Wells and Kedes, 1985). Core histones and histone variants can be defined as 
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homomorphous or heteromorphous depending on the amino acid sequence difference from 
the main histone proteins that are expressed during S-phase (West and Bonner, 1980). In 
general histone proteins that have small sequence differences are classified as homomorphous 
(i.e. H3.1, H3.2 and H3.3 or H2A.1 and H2A.2), whereas histones that have profound amino 
acid differences in their sequence that affect large domains are named as heteromorphous (i.e. 
macroH2A, H2A.Bbd, H2A.X, H2A.Z and CENP-A). 
 
The two prominent core histone variants families belong to H3 and H2A. In contrast, H2B 
and H4 do not show a high level of sequence variability, this is perhaps due to the role of 
these two histones in maintaining the histone octamer within the Nucleosome Core Particle 
(NCP) or promoting higher order chromatin structure (Malik and Henikoff, 2003). There are 
no H4 variants known thus far, whereas H2B has different tissue-specific variants that are 
expressed in sperm of vertebrate and invertebrate. In humans there are three H2B variants that 
have been discovered so far: TH2B, human testis specific H2B (hTSH2B) and H2B family 
member W testis- specific (H2AFWT) (Churikov et al., 2004; Zalensky et al., 2002)  
 
The incorporation of the histone variants has been associated with several processes involved 
in cell viability and proliferation such as DNA replication, transcription, recombination and 
repair. Interestingly, in the last years an abnormal expression of histone variants has been 
detected in several types of cancer, suggesting a putative role in cancer progression and 
development (Vardabasso et al., 2013). 
The different histone variants belonging to the H2A and H3 families will be described below 
with particular attention to H2A.Bbd and macroH2A. 
 
2.6.1 H3 histone variants 
Five H3 variants have been well characterized thus far. Two of them are the canonical 
variants that have their peak of expression during S-phase and that are named H3.1 and H3.2, 
generally referred as H3. The other three replacement variants are expressed outside S-phase. 
They are H3.3, the centromere-specific variant CenH3 (also named CENP-A in mammals) 
(Figure 2.4) and the testis-specific histone H3t. Recently, two new H3 histone variants (H3.X 
and H3.Y) have been identified in primates (Wiedemann et al., 2010).  
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Figure 2.4 Schematic representation of the mammalian H3 histone variants and their functional domains. 
The H3 histone variants and the canonical histone H3 are represented according to their amino acids length and 
together with the histone folding domain (HFD) and the histone loops L1 and L2. The sequence divergence from 
H3.1 is depicted using different colors shades. Significant differences in the L1 loop (L1) are highlighted in red 
(Figure adapted after (Vardabasso et al., 2013)).   
 
The H3 histone variant H3.3 differs from the canonical H3.1 by only five amino acids, but 
this small difference is sufficient for a very specific function of H3.3 (Szenker et al., 2011).  
Through the use of GFP-tagged histones it was shown that H3.3 is incorporated into 
chromatin outside replication whereas H3.1 incorporation happens only during DNA 
replication (Ahmad and Henikoff, 2002). Even though the crystal structure of the nucleosome 
containing H3.3 is very similar to the nucleosome containing H3.1, those with H3.3 show 
lower stability (Tachiwana et al., 2011). Genome wide analysis of the localization of H3.3 in 
Drosophila and mammals revealed that H3.3 is enriched at the gene body of actively 
transcribed genes and at the promoter of active and inactive genes (Szenker et al., 2011). 
Interestingly, H3.3 incorporation has also been shown at pericentric heterochromatin and 
telomers in mouse ES cells and Mouse Embryonic Fibroblasts (MEF) (Goldberg et al., 2010; 
Lewis et al., 2010). The latest discoveries about the H3.3 localization at the silent chromatin 
and the fact that mutants that lack H3.3 still have a normal gene expression challenged the 
initial idea that H3.3 enrichment was solely important for gene activation and transcription. 
 
CENP-A histone variant is a rapidly evolving member of the H3 family that replaces H3 at 
the centromere. Since CENP-A is important for centromere identity and structure, this variant 
is essential for cell survival. In yeast CENP-A is named as Capping Enzyme Suppressor 4-p 
(Cse4p) and in Drosophila as Centromere Identifier (Cid) (Black and Cleveland, 2011). 
CENP-A is highly divergent from H3 with only 60% similarity in the HFP domain and a 
distinct N-terminal tail (Sullivan et al., 1994) (Figure 2.4). The N-terminal sequence varies in 
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different species in both length and sequence and a histone fold domain that contains the 
CATD sequence important for targeting CENP-A to the centromere (Black et al., 2004). 
Another important domain for the CENP-A specific centromere function is the hydrophobic 
C-terminus (CAC) that mediates the association of CENP-A with a second very important 
centromere protein CENP-C (Kato et al., 2013). The nucleosomes containing H3 or CENP-A 
do not show significant differences but CENP-A differs from the canonical H3 in its α-N 
helix, with at least one helical turn shorter than in H3, and the L1 loop, that has two additional 
residues (Tachiwana et al., 2011). Remarkably, the loading of CENP-A does not follow the 
time of its expression. Even though the loading process is still not fully understood it is clear 
that, whereas CENP-A expression peaks in G2, the loading of this histone variant at 
centromeres only happens during G1 (Jansen et al., 2007). 
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2.6.2 H2A histone variants 
In the H2A family there are variants for the canonical H2A and replacement variants. The 
first two variants identified for the canonical H2A are H2A.1 and H2A.2, which differ in one 
amino acid in position 51 (Franklin and Zweidler, 1977). Several differences between the 
canonical H2A and its variants are located on the C-terminal tail and the docking domain 
(Figure 2.5). 
 
 
Figure 2.5 Schematic representation of the mammalian H2A family and their functional domains. 
The different H2A histone variants and the canonical histone H2A are represented according to their amino acids 
length and together with the histone folding domain (HFD) and the histone loops L1 and L2. The sequence 
divergence from the canonical H2A is depicted using different colors shades. Significant differences in the L1 
loop (L1) and the docking domain (dashed line) sequences are highlighted in red. The H2A residues that are part 
of the acidic patch domain are represented in pink (Figure adapted after (Vardabasso et al., 2013)). 
 
Initially, it was shown that the removal of 15 amino acids at the C-terminal tail of the H2A 
histone decreases the H2A-H2B dimer affinity for the (H3-H4)2 tetramer, leading to the 
hypothesis that the carboxyl terminal tail of H2A is important for stabilizing the nucleosome 
structure (Eickbush et al., 1988). Recently the C-terminal domain of the histone H2A has 
been shown to interact with the linker histone, and variations in the C-terminal domain could 
affect internucleosomal interaction and chromatin fibre structure (Vogler et al., 2010). For 
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this reason, H2A histone variants that carry an altered C-terminal tail, as for example 
H2A.Bbd, are thought to substantially modify the chromatin fibre structure. 
 The docking domain is responsible for the interaction between the H2A-H2B dimer and the 
(H3- H4)2  tetramer and includes three of the seven amino acids that are part of the acidic 
patch (Luger et al., 1997) (Figure 2.6). As for the C-terminal tail, changes in the docking 
domain influence the stability of the dimer to tetramer interaction. 
  
 
Figure 2.6 H2A relevant domains in the nucleosome structure. 
Structural differences between the canonical H2A and its replacement variants are fundamental for the 
nucleosome stability. The main differences in the H2A family are found in the docking domain, the acidic patch 
and the L1 loops. All these domains mediate the inter- and intra-nucleosomal interactions. The histones are 
depicted as follows: H3- light blue; H4- green; H2A-yellow; H2B-red (Figure adapted after (Luger et al., 2012)). 
  
In the nucleosome the L1 loops of the two H2A histones mediate the interaction between the 
two H2A-H2B dimers (Figure 2.6). This region shows a high diversity among the H2A 
variants influencing the stability of the dimers within the nucleosome. 
 
H2A.Z is highly conserved among species, but compared to the canonical H2A, H2A.Z shows 
only 60% sequence identity. In organisms such as Tetrahymena thermophila, Drosophila 
melanogaster, Xenopus laevis and Mus musculus, H2A.Z is essential for the organism 
survival (Faast et al., 2001; Iouzalen et al., 1996; Liu et al., 1996; van Daal and Elgin, 1992). 
So far three isoforms have been identified for H2A.Z: H2A.Z.1, H2A.Z.2 and H2A.Z.2.2 
(Bönisch et al., 2012; Matsuda et al., 2010) (Figure 2.5). 
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H2A.Z.1 and H2A.Z.2 differ by only three amino acids at the protein level, but they are 
encoded by unique nucleotide sequences (Dryhurst et al., 2009). The discovery of a third 
isoform increased the complexity of the H2A.Z biology. The third isoform, H2A.2.2, has a 
shorter and specific C-terminus and is loosely associated with chromatin. Nucleosome 
containing H2A.2.2 are the least stable nucleosome described so far (Bönisch et al., 2012). It 
is important to specify that what is normally referred to as H2A.Z is the isoform H2A.Z.1. 
Despite the significant difference between H2A.Z and the canonical H2A, the nucleosome 
containing H2A.Z is structurally very similar to the nucleosome containing H2A (Suto et al., 
2000). The major differences in the nucleosomes containing either H2A or H2A.Z are found 
in the L1 loop, which is important for the H2A-H2B dimer interaction. Further differences are 
present in the C-terminal docking domain, which has less than 40% amino acid identity with 
the canonical H2A. This region is important for the interaction with H3/H4 and it is a putative 
platform for nucleosome remodeling activities. Modifications in the C-terminal docking 
domain could have effects on the interaction between nucleosomes, or between nucleosomes 
and the linker histone, thus altering the higher order chromatin structure (Suto et al., 2000; 
Thakar et al., 2009). There are conflicting data on the influence of H2A.Z on nucleosome 
stability. On one hand, several studies propose a destabilization of the nucleosome 
containing- H2A.Z (Abbott et al., 2001; Suto et al., 2000); on the other hand, other 
experiments support a rather stable conformation of the nucleosome-containing H2A.Z (Park 
et al., 2004; Thambirajah et al., 2006). However, these varied outcomes could be the result of 
technical differences among the performed experiments (Zlatanova and Thakar, 2008). 
 
H2A.Z is expressed during the all cell cycle and incorporated in a replication- independent 
manner. Even though the incorporation of H2A.Z influences several cellular processes, the 
best characterized function of H2A.Z is its role in transcriptional regulation. H2A.Z is 
enriched at gene promoters in yeast and higher eukaryotes (Guillemette et al., 2005; Raisner 
et al., 2005). Together with its localization at promoter sites, H2A.Z is also found at 
regulatory regions such as insulator and enhancers (Zlatanova and Thakar, 2008). Notably, it 
was shown that H2A.Z has active and repressive functions (Marques et al., 2010). The 
different effects on transcription regulation may suggest that it is not the presence of H2A.Z 
itself that influences the final readout of gene expression, but rather the combination of 
different factors such as the presence of specific H2A.Z binding factors and the combination 
with other histone variants and their post-transcriptional modifications (PTMs). 
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Of particular interest is the histone variant H2A.X, which is fundamental in preserving 
genome integrity. H2A.X is highly similar to H2A in its HFD domain, however it is 
characterized by the presence of a long C-terminal domain containing a serine-glutamine (SQ) 
motif followed by an acidic and a hydrophobic residue [SQ(E/D)φ] (Bönisch and Hake, 2012). 
H2A.X plays an important role in the DNA damage response (DDR). After DNA double 
strand break (DSB), H2A.X gets phosphorylated and it can be visualized at specific foci, 
which in mammals cover several Mb on each DSB side (Rogakou E. P. 1999). In Humans the 
presence of the serine S139 in the SQ(E/D)φ motif is fundamental for the H2A.X specific role 
in DNA repair.  Despite the importance of H2A.X in genome stability, the effects of H2A.X 
on nucleosome stability are still largely controversial with results pointing in diverging 
directions (Bönisch and Hake, 2012). 
 
2.6.2.1 H2A.Bbd 
H2A.Bbd (H2A. Barr-body-deficient) was first described by Chadwick and Willard as a new 
histone variant excluded from the inactive X that localizes to H4 hyperacetylated regions 
(Chadwick and Willard, 2001a). Recently, a new nomenclature was suggested for several 
histone variants based on historical usage and phylogenetic relationship among histones. 
According to this new nomenclature, H2A.Bbd should now be named as H2A.B (Talbert et 
al., 2012). However, in this thesis the prior nomenclature and the name H2A.Bbd will be used.  
H2A.Bbd is present only in mammals and, among all histones, is the most quickly evolving 
histone known as of yet (Eirín-López et al., 2008). 
 
Like other histone variants, H2A.Bbd is encoded by a polyadenylated mRNA. Sequence 
alignment showed that H2A.Bbd is only 50% identical to the canonical H2A. Interestingly, 
none of the residues that are post-translationally modified in H2A are conserved in H2A.Bbd. 
Moreover, H2A.Bbd lacks the C-terminal tail and part of the docking domain (Bao et al., 
2004; Chadwick and Willard, 2001a), which results in a slightly shorter and less basic protein 
with a molecular weight of 12.7 kD (Figure 2.5). H2A.Bbd is also characterized by the lack of 
the acidic patch, which is important for inter-nucleosomal interactions (Zhou et al., 2007). 
For this reason H2A.Bbd is also called H2A.Lack of acidic patch 1-4 (H2A.Lap1-4) in mouse 
(Soboleva et al., 2011). 
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H2A.Bbd cofractionates and copurifies with core histones after chromatin fractionation and 
sedimentation (Chadwick and Willard, 2001a). This observation, together with electrophoretic 
mobility shift assay (EMSA) experiments, confirmed that H2A.Bbd can be incorporated into 
nucleosomes and efficiently replaces canonical H2A (Angelov et al., 2004). The nucleosomes 
containing H2A.Bbd are influenced by different perturbations and alterations in the DNase I 
footprinting pattern (Angelov et al., 2004). Nucleosomes containing H2A.Bbd are not able to 
refold into histone octamers under high salts conditions. This suggests that the interaction 
between H2A.Bbd-H2B dimers and (H3-H4)2 tetramers is impaired resulting in a reduced 
nucleosome stability (Bao et al., 2004; Eirín-López et al., 2008). 
Initially, it was shown that H2A.Bbd containing nucleosomes organize only 118 bp in 
contrast to the canonical 147 bp (Bao et al., 2004). More recent studies however, in which 
microccocal nuclease digestion was combined with atomic force microscopy and electron 
cryo-microscopy, revealed that the H2A.Bbd nucleosome organizes 130 bp of DNA 
compared to the canonical NCPs (Doyen et al., 2006). 
 
H2A.Bbd lacks the C-terminal domain and the docking domain. To understand which domain 
is responsible for the particular nucleosomal conformation of the H2A.Bbd containing NCPs, 
H2A chimeras containing the H2A.Bbd domains were generated. These experiments showed 
that the lack of the docking domain and not the C-terminal tail is the reason for the relaxed 
DNA organization in the nucleosome containing H2A.Bbd. These experiments also pointed to 
a role of the docking domain in organizing the last 14 base pairs in the nucleosome containing 
H2A.Bbd (Bao et al., 2004). These results are consistent with the role of the docking domain 
in stabilizing the nucleosome octamer. Interestingly, when a H2A.Bbd mutant containing the 
docking domain and the C-terminal tail of the canonical H2A was generated some of the 
properties of the canonical H2A-NCP were re-established, such as its stability and the length 
of the organized DNA (Doyen et al., 2006).  
 
Another important contribution to the instability of the nucleosome containing H2A.Bbd is 
given by the absence of the acidic patch. It was recently shown that the alteration of the acidic 
patch in the nucleosome-containing H2A.Bbd reduces the magnesium-dependent 
internucleosomal interactions that guide folding of nucleosomal arrays (Zhou et al., 2007). 
In summary, the unfolded state of the chromatin fibres containing H2A.Bbd is very likely a 
consequence of the differences of both the docking domain and the acidic patch. 
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In addition to several structural differences, the nucleosome-containing H2A.Bbd has also 
different functional properties compared to the canonical NCP. Indeed, it was shown that the 
H2A.Bbd-nucleosome cannot be mobilized by the SWI/SNF and the ACF remodeling 
machinery, even though the presence of H2A.Bbd does not affect the binding of the 
remodelers to chromatin (Angelov et al., 2004).  
 
Mammalian H2A.Bbd is expressed at high levels in testis and to a lower degree in the brain. 
In mice H2A.Bbd is expressed in specific stages of spermatogenesis when chromatin 
undergoes massive remodeling caused by the histones to protamines exchange (Chadwick and 
Willard, 2001a; Ishibashi et al., 2010). Recently, it was shown that H2A.Bbd together with 
the histone variant H2A.Z contribute to create a specific chromatin environment at promoters 
of active genes during spermatogenesis where H2A.Bbd occupies position -1 and H2A.Z 
position -2 relative to the transcription start site (TSS) (Soboleva et al., 2011).  
 
2.6.2.2 MacroH2A 
MacroH2A is a H2A variant characterized by the presence of a large macro domain that 
constitutes a binding module for nicotinamide adenine dinucleotide (NAD) metabolites 
(Kustatscher et al., 2005) (Figure 2.5). The structure of macroH2A consists in an N-terminal 
histone region connected to an H1-like linker region to a non-histone macro domain. This 
results in a large histone protein of about 40 kD (Figure 2.5). There are two genes encoding 
for macroH2A: macroH2A.1/H2AFY and macroH2A.2/H2AFY2. MacroH2A.1 encodes for 
two alternatively spliced forms, macroH2A.1.1 and macroH2A.1.2. MacroH2A.2 is 68% 
identical to macroH2A.1. Both, macroH2A.1 and macroH2A.2 localize to the inactive X 
chromosome (Chadwick and Willard, 2001b). MacroH2A preferentially forms heterotypic 
nucleosomes where both canonical H2A and macroH2A, are present (Chakravarthy et al., 
2005a). 
 
The histone variant macroH2A is enriched on the inactive X chromosome in mammals where 
it contributes to the maintenance of the repressed state and facilitates dosage compensation in 
mammals (Costanzi and Pehrson, 1998). Several studies have reported the enrichment of 
macroH2A on the inactive X chromosome. This particular localization of macroH2A was 
challenged by using GFP tagged macroH2A and fluorescent recovery after photobleaching 
(FRAP). This study suggested that the enrichment of macroH2A on the highly compacted 
Introduction 
 19 
inactive X may reflect the higher chromatin concentration and not a real enrichment of the 
histone variant (Perche et al., 2000). Subsequently, Chromatin Immunoprecipitation (ChIP) 
based approaches revealed that the inactive X chromosome in liver cells contains 1.5 to 2 
times more MacroH2A in females compared to males (Mietton et al., 2009). Nevertheless, 
from the first study that showed the localization of macroH2A on the inactive X chromosome, 
this histone variant has always been associated to transcriptional repression. Several in vitro 
studies of nucleosomes containing macroH2A have given insight on how this variant could 
contribute to chromatin repression. Indeed, even if the structure of the macroH2A NCPs is 
similar to the canonical NCPs, there is a four amino acid difference in the LI loop responsible 
for the interaction of H2A-H2B dimers, which may affect the structure of the macroH2A 
containing NCPs. In solution the macroH2A NCPs were found to be more stable and less 
prone to H2A-H2B dimer exchange by the histone chaperone NAP1 (Abbott et al., 2001; 
Chakravarthy et al., 2005a). Interestingly, it was shown that by introducing the macroH2A L1 
loop into the canonical H2A, the H2A chimera was targeted to the inactive X (Nusinow et al., 
2007b). 
 
Due to the particular localization of macroH2A, many studies focused on the role of this 
variant in the X inactivation process (Costanzi and Pehrson, 1998; Costanzi et al., 2000; 
Hernández-Muñoz et al., 2005; Perche et al., 2000). It is important to note that macroH2A is 
also present in organisms that do not undergo X inactivation and that macroH2A level 
expression levels are similar in male and female (Buschbeck and Di Croce, 2010; Rasmussen, 
1999). These two fascinating features of macroH2A prompted new investigations in studying 
its potential role outside X inactivation. In NT2/D1 cells and by using promoter array-based 
analysis of immunoprecipitated chromatin material it was shown that macroH2A is enriched 
on promoters of key developmental genes (Buschbeck et al., 2009). However, it seems that 
macroH2A has different roles in polypotent cells, such as stem and pluripotent cells, when 
compared to terminally differentiated cells (Buschbeck and Di Croce, 2010). In pluripotent 
cells, macroH2A is localized to key developmental genes, whereas in liver cells, macroH2A 
does not show any particular enrichment on specific developmental genes (Changolkar et al., 
2010). Moreover, in Namalwa cells, a human B-cell line, macroH2A.1 knockdown caused a 
dramatic derepression of the IL-8 gene that is normally not expressed in these cells 
(Agelopoulos and Thanos, 2006).  
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It is evident that there are several mechanisms that modulate the macroH2A function in 
different tissues. One type of regulation may be related to different interaction partners of 
macroH2A. Indeed, many proteins have been identified so far that could specifically interact 
with macroH2A.  Some of those factors show a preferential binding for either macroH2A.1.1 
or macroH2A.1.2. An interesting example is the poly-ADP ribose polymerase 1 (PARP1) 
(Nusinow et al., 2007a). Although the three macroH2A variants are able to inhibit PARP1 via 
their non-histone region (NHR), only macroH2A.1.1 is able to bind polymeric and 
monomeric ADP-ribose, O-acetyl-ADP ribose (Kustatscher et al., 2005; Timinszky et al., 
2009). 
In COS cells, the NHR of macroH2A.1.2 was shown to bind the histone deacetylases 1 and 2 
(HDAC1/2) (Chakravarthy et al., 2005b). In a yeast two-hybrid approach macroH2A.1.2 was 
found to interact with the speckle-type POZ domain protein (SPOP) and later this interaction 
was found to be important for the deposition of macroH2A.1.2 on the inactive X chromosome 
(Hernández-Muñoz et al., 2005; Takahashi et al., 2002). Recently, macroH2A has also been 
shown to localize at Senescence-Associated Heterochromatic Foci (SAHFs), revealing new 
questions about the role of this variants in chromatin (Zhang et al., 2005). 
 
2.7 Histone variants in cancer 
In the last years it became clear that, together with their important role in shaping chromatin 
structure and gene expression, histone variants play a key role in cancer progression and 
development. Abnormal expression of different histone variants has been found in several 
types of cancer. Due to their role in the regulation of key cellular and developmental 
processes, the deregulation of histone variants expression has been linked to tumor initiation 
and progression. In some cases, histone variants expression levels correlate with tumor 
malignancy thus promoting the use of a particular histone variant as a prognostic indicator in 
cancer (Hua et al., 2008; Sporn and Jung, 2012).  
In the H2A family, three variants, H2A.Z, H2A.X and macroH2A, have been identified in 
playing a role in cancer development. The first evidence comes from microarray studies that 
detected abnormal expression level of H2A.Z in colorectal, lung, breast and bladder cancers 
(Dunican et al., 2002; Rhodes et al., 2004; Zucchi et al., 2004). Increased H2A.Z expression 
is also detected in metastatic melanoma cell lines. Therefore, H2A.Z has been classified as an 
oncogene but the way it acts to promote cancer progression is still largely unknown in several 
cancer types. The simple explanation is that H2A.Z modulates gene expression or regulatory 
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and non-coding regions of genes that are important for cancer development. However, as 
discussed above, H2A.Z participates in several other cellular processes such as DSBs repair, 
telomeres integrity, genome stability and chromosome segregation (Greaves et al., 2007; Shia 
et al., 2006; Xu et al., 2012).  
 
Due to its important role in Double Strand Breaks (DSBs) repair, H2A.X is considered a key 
factor in tumor progression. In this regards it is surprising that H2A.X null mice are not 
cancer prone, but they only develop an increased number of T and B lymphomas and solid 
tumors in the context of p53 deficiency (Bassing et al., 2003; Celeste et al., 2003). Several 
studies promoted the idea of H2A.X as a ‘genome caretaker’ and tumor suppressor in defined 
genetic context (Vardabasso et al., 2013).  
As for H2A.X, macroH2A is also considered a tumor suppressor. Its expression is reduced in 
several types of cancer such as colon, lung and melanoma tumors (Kapoor et al., 2010; Sporn 
et al., 2009; Sporn and Jung, 2012). In general the down-regulation of macroH2A.1.1 and 
macroH2A.2 is negatively correlated to cell proliferation (Sporn et al., 2009). As macroH2A 
is a marker for cellular senescence, which is considered a barrier against tumor progression, it 
is likely that a low expression of macroH2A allows the cells to bypass senescence thus 
promoting cancer development. Interestingly, macroH2A is enriched in rodent lung adenomas 
but it is absent or down regulated in lung carcinomas. Indeed in adenomas there is a high 
number of senescent cells whereas in carcinomas cells overcome senescence and show a high 
proliferation rate (Sporn et al., 2009). 
 
Apart from variants of H2A, the H3 variants CENP-A and H3.3 have also been found to play 
a role in cancer development. There is much evidence that CENP-A is overexpressed in 
several cancer types. Some examples are the colorectal cancer, lung adenocarcinoma, breast 
cancer, hepatocellular carcinoma (HCC) and invasive testicular germ cell tumors (Vardabasso 
et al., 2013). As mentioned above CENP-A is essential for the centromere identity. Thus it is 
not surprising that the mis-regulation of its expression could promote severe mitotic defects in 
the cells. Interestingly, it was recently shown that the overexpression of CENP-A in 
hepatocellular carcinoma (HCC) promotes cell growth and reduce apoptosis by deregulating 
genes involved in apoptosis and cell proliferation (Li et al., 2011). 
H3.3 involvement in cancer development was already reported years ago (Graber et al., 1996). 
However, H3.3 represents the first case where a mutation in the coding sequence was detected. 
Two recent studies reported a missense mutation of H3.3 in pediatric Glioblastoma 
Introduction 
 22 
Multiforme (GBM) and in Diffuse Intrinsic Pontine Gliomas (DIPGs) (Schwartzentruber et 
al., 2012; Wu et al., 2012). In 31% of GBMs cases, mutations in lysine 27 (K27) or in G34 
were reported.  
Together with the direct alteration of the histone variants expression or their mutation, in 
many cancer types there are also changes in their chaperones expression levels or remodeling 
complexes interacting with specific histone variants (Heaphy et al., 2011; Schwartzentruber et 
al., 2012; Vardabasso et al., 2013; Wu et al., 2012). 
Despite the abundance of data generated in the last years that confirm the involvement of the 
histone variants in cancer progression, many questions about how they contribute to the 
disease progression still need to be answered.  
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3 Aim of the thesis 
The core unit of the chromatin, the nucleosome, plays a central role in the regulation of 
chromatin structure and gene expression regulation. Together with the histone modifications, 
the canonical histones and their variants are the main regulators of the nucleosome structure 
and accessibility.  
 
The main aim of this project was to analyze the protein composition of chromatin domains 
containing the histone variants H2A.Bbd and macroH2A. 
H2A.Bbd and macroH2A have been extensively studied for their influence on the nucleosome 
structure and they opposing nuclear localization. Indeed H2A.Bbd is enriched on H4 
hyperacetylated foci and excluded from the Barr body, whereas macroH2A localizes to 
heterochromatic regions and plays a role in the X inactivation process (Chadwick and Willard, 
2001a; Costanzi and Pehrson, 1998). 
 
For this aim the histone variant H2A.Bbd and macroH2A.1.2 were tagged with GFP and 
expressed in Mouse Embryonic Fibroblasts (MEF). Mass spectrometry analysis was then 
performed on chromatin fragments containing the GFP-tagged histone variants. Interesting 
differences were found that reflect the opposing nuclear localization of these two variants 
confirming that mass spectrometry and label free quantification are valid and powerful tools 
to study complex samples like chromatin domains. 
 
Interestingly based on the proteomic results it was possible to reveal new feature for the 
histone variant H2A.Bbd. The mass spectrometry data showed an interesting link between 
H2A.Bbd and factors involved in DNA replication and repair. Based on this new finding, the 
mass spectrometry data were validated by using different microscopy techniques that 
confirmed the presence of GFP-H2A.Bbd at sites of DNA replication and DNA damage.  
 
It was further investigated whether the expression of GFP-H2A.Bbd in MEF cells have an 
effect on cell cycle or DNA sensitivity and it was found that the MEF cells expressing GFP-
H2A.Bbd have shorter S-phase and higher sensitivity to DNA damage. 
 
Due to its specific tissue specific expression in post-mitotic round spermatids it is possible to 
exclude that H2A.Bbd could play a role in somatic cells DNA replication. However this study 
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demonstrated that H2A.Bbd is abnormally expressed in Hodgkin’s Lymphoma cells (HL) 
where the level of expression inversely correlates with the doubling time of different HL cell 
line. 
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4 Results 
4.1 Characterization of mouse embryonic fibroblasts (MEFs) expressing GFP-
tagged histone variants  
Histone variants H2A.Bbd and macroH2A.1.2 have been found to localize at different 
chromatin loci. While H2A.Bbd localizes to regions enriched in acetylated H4, macroH2A.1.2 
is mostly co-localizing with H3K27me3 (Chadwick and Willard, 2001a; Costanzi and 
Pehrson, 1998). To better understand the functional properties of H2A.Bbd and 
macroH2A.1.2 containing chromatin, mass spectrometry analysis was performed on 
chromatin domains containing GFP-tagged histone H2A.Bbd and macroH2A.1.2. To do this, 
female MEF cells were used that stably express GFP-tagged version of H2A.Bbd and 
macroH2A.1.2. The MEF cells expressing GFP- tagged H2A.Bbd and H2A were established 
by Clemens Boenisch (A.G. Hake), whereas the GFP-macroH2A.1.2 expressing MEFs were 
generated by me using an expression plasmid provided by Dimitri Thanos. In all experiments, 
the canonical histone H2A was also included as a control to discriminate specific protein 
factors that bind H2A.Bbd and macroH2A.1.2 containing chromatin from generic chromatin 
binding factors.  
To obtain a homogenous population of cells expressing the GFP-tagged histone variants, the 
transfected MEF cells expressing the GFP-tagged histone variants were first selected with the 
G418 antibiotic and then by isolating single cells clones using a MoFlo sorter. Several clones 
were obtained and analyzed by FACS to detect the expression levels of the GFP-tagged 
histone variants (data not shown). 
 
Based on similar expression levels detected by fluorescence-activated cell sorting (FACS) 
analysis, two clones were chosen expressing GFP-H2A.Bbd and GFP-H2A, respectively. 
Unfortunately, the expression of GFP-macroH2A.1.2 ceased upon extended passaging of the 
first three single cell clones selected. Therefore, a population derived from six sorted cells 
was used for all experiments instead. Within this population, GFP-macroH2A.1.2 expression 
was maintained in most of the cells even after two month of culturing. The expression of the 
GFP-tagged histone variants was measured by FACS analysis and compared to non-
transfected MEF cells (Figure 4.1 A).  
Furthermore, GFP-tagged histone variants expression levels were also determined by Western 
blotting using antibodies directed against the GFP-tag (Figure 4.1 B). MEF cells transfected 
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with GFP-H2A.Bbd and GFP-H2A show similar level of expression, whereas GFP-
macroH2A.1.2 is expressed at lower levels. 
 
 
Figure 4.1 Female MEFs stably express the GFP-tagged histone variants. 
(A) FACS profile of female MEF cell populations derived from sorted cell clones that express H2A.Bbd, 
macroH2A.1.2 and H2A tagged with GFP (solid line) in comparison to non-transfected control female MEF 
cells (dotted and filled histogram). (B) Western Blot analysis of GFP-tagged histone variants expression levels 
with antibody against GFP. Detection of histone H3 served as loading control. The bands corresponding to the 
GFP-tagged histones are indicated: (*) GFP-H2A.Bbd, (**) GFP-H2A and (***) GFP-macroH2A.1.2. 
 
In order to verify the localization pattern of the GFP-tagged histone variants H2A.Bbd and 
macroH2A.1.2, MEF cell lines were stained with an anti-H3K27me3 antibody, which marks 
the inactive X-chromosome forming the Barr body. Consistent with previous reports 
(Costanzi and Pehrson, 1998), GFP-tagged macroH2A.1.2 was slightly enriched on the Barr 
body, whereas GFP-H2A.Bbd was excluded (Figure 4.2). This confirmed that in MEF cells 
the GFP-tagged histone variants indeed mark different chromatin domains. 
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Figure 4.2 GFP-tagged histone H2A.Bbd and macroH2A.1.2 mark different chromatin domains. 
Nuclear localization of the histone variants GFP-H2A.Bbd and GFP-macroH2A.1.2 in female MEFs stained 
with H3K27me3 (red). Arrows indicate the Barr body. Scale bar: 5 µm.   
 
4.2 Purification and accessibility of chromatin containing GFP-tagged histone 
variants 
Chromatin is organized in large domains in which not all the nucleosomes contain the same 
histone isoforms (Loyola et al., 2006). Therefore, to be able to study entire chromatin 
domains that contain the GFP-tagged histone variants H2A.Bbd and macroH2A.1.2, 
chromatin was digested with micrococcal nuclease (MNase) to obtain fragments of different 
lengths. 
After chromatin digestion and centrifugation of the nuclear matrix pellet, the first supernatant 
was collected (S1) at 150 mM NaCl. The chromatin fragments retained in the nuclear pellet 
were then extracted using 300 mM NaCl to release the remaining chromatin (second 
supernatant (S2) (Figure 4.3 A). The chromatin fragments obtained in S1 and S2 differ in size 
with mononucleosomes preferentially released in the S1 and larger chromatin fragments in the 
S2 (Figure 4.3 B). 
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Figure 4.3 Chromatin from the MEF cells expressing the GFP-tagged histone variants is released after 
MNase digestion. 
(A) Chromatin purification protocol. After nuclei isolation the chromatin is digested with MNase. The nuclei are 
centrifuged and the first supernatant (S1) is collected. The remaining chromatin is extracted with 300mM NaCl 
and the second supernatant (S2) containing chromatin is collected. (B) DNA analysis of the first and second 
supernatants containing chromatin (S1 and S2, respectively). 
 
The release of the GFP-tagged histone variants was followed by western blotting. The S1, S2 
and the boiled nuclear pellet were analyzed for the presence of the tagged histone variants 
with or without MNase digestion (Figure 4.4). The GFP-tagged histone variants are mainly 
released in the S1 and S2. Only GFP-H2A.Bbd is still visible in the boiled nuclear pellet. This 
suggested that the physiochemical properties of the chromatin fibres containing the GFP-
histone variants are similar with some differences for GFP-H2A.Bbd. In addition, no 
significant pools of free histone variants exist in isolated nuclei in the absence of MNase 
where the GFP-tagged histone variants are not released in the S1 and S2 but are retained in 
the pellet (Figure 4.4). 
 
Figure 4.4 The GFP-tagged histone variants are only released after MNase digestion. 
Western Blot analysis of the GFP-tagged histone variants release compared to H3 in presence or absence of 
chromatin MNase digestion. 
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Chromatin is organized in domains where nucleosomes containing the histone variants are 
interspersed with nucleosomes containing canonical histones (Loyola et al., 2006). 
Furthermore, different chromatin regions differ for their solubility and this could also reflect 
several biological differences as Heinekoff proposed in 2008 (Henikoff et al., 2009). 
Therefore, the S1 and the S2 fractions were pooled for all further experiments.  
 
It was shown that the incorporation of the histone variants H2A.Bbd and macroH2A into 
chromatin causes specific modifications on the nucleosome structure and stability (Bönisch 
and Hake, 2012). In particular the nucleosome containing H2A.Bbd was shown to be rather 
unstable compared to the canonical H2A-containing nucleosomes. The nucleosomes 
containing H2A.Bbd have been proven to organize only 130 bp of DNA (Doyen et al., 2006) . 
For this reason it was asked whether the ectopic expression of H2A.Bbd could lead to a more 
accessible chromatin structure. To answer this question the chromatin containing the GFP-
tagged histone variants was digested with different MNase concentration. The digested DNA 
was precipitated and separated by agarose gel electrophoresis (Figure 4.5A). The subsequent 
calculation of the mononucleosomes percentage revealed no major differences in bulk 
chromatin accessibility in the MEF cells expressing the three different GFP-tagged histone 
variants compared to the non- transfected cells (Figure 4.5 B).  
Figure 4.5 GFP-tagged histones expression does not alter bulk chromatin structure in MEF cells. 
(A) DNA gel of the chromatin digestion pattern after MNase treatment in cells expressing GFP-H2A, GFP-
H2A.Bbd and GFP-macroH2A.1.2. (B) Percentage of mononucleosomes after digestion with different 
concentration of MNase in MEF cells expressing the GFP-tagged histone variant H2A, H2A.Bbd and 
macroH2A.1.2.  
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4.3 Proteomic analysis of chromatin containing GFP tagged H2A.Bbd, 
macroH2A.1.2 and H2A 
Using GFP- affinity purification, chromatin-containing the GFP-tagged histone variants was 
specifically isolated. The representative Coomassie gel shows the purified fractions and the 
input chromatin (Figure 4.6). The bands corresponding to the three tagged histone variants are 
clearly visible in the gel. Together with the tagged histone variants several other non-histone 
proteins bands are detected. In addition, the exclusive presence of chromatin bound histones 
and the presence of DNA in the GFP-tagged histone purified fraction compared to the non-
transfected cells (no-GFP) confirmed that the samples are composed of chromatin without the 
presence of soluble histones fraction (Figure 4.4 and Figure 4.6 B). 
 
Figure 4.6 The GFP purified fraction is enriched in chromatin containing the GFP-tagged histone variants. 
(A) Coomassie blue staining of SDS-PAGE gel of chromatin fibres purified by GFP-nanotrap beads. Chromatin 
input and purified fractions are shown. The bands corresponding to the GFP-tagged histones are indicated: (*) 
GFP-H2A.Bbd, (**) GFP-H2A and (***) GFP-macroH2A.1.2. (B) Isolated DNA after chromatin fibres 
purification with the GFP-nanotrap beads. The ratio between the DNA concentration in the chromatin containing 
GFP-tagged histones and the non-transfected cells is shown before and after the affinity purification (black and 
grey bars respectively). 
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As expected, the four canonical histones are also present in the purified fraction (Figure 4.6 
A). This is consistent with previous reports that suggested that chromatin domains are 
composed by canonical nucleosomes and nucleosome containing the histone variants (Loyola 
et al., 2006). 
 
To identify non-histone proteins present in the sample, in-gel trypsin digestion was performed 
using the entire lane cut into 8 pieces. The eluted peptides were analyzed by Mass 
spectrometry. A total number of 1428 proteins were identified using the Andromeda 
algorithm of the MaxQuant protein analysis package (Cox et al., 2011). The overlap among 
replicates for every GFP-histone pull down was calculated based on protein identification.  
Using these criteria more than the 50% of the identified proteins are present in at least two 
replicates. The overlap varies among the GFP-tagged histone samples: 53.4% for GFP-
H2A.Bbd, 51.6% for GFP-H2A and 53.1% for GFP-macroH2A.1.2. (Figure 4.7). 
 
 
 
Figure 4.7 Identified protein overlap among the replicates. 
Protein factors identified after the GFP-H2A variants chromatin purification using the GFP nanotrap beads are 
displayed in Venn diagrams showing the identified proteins overlap in three independent biological replicates 
(e.g. H2A.Bbd exp.#1, #2 and #3). 
 
In order to quantify the amount of every single protein in the pull down sample and compare 
the chromatin fragments that contain different histone variants, the Intensity Based Absolute 
Quantification (iBAQ) values were used (Schwanhäusser et al., 2011). The iBAQ values are 
calculated using the sum of all the tryptic peptides intensities divided by the number of 
theoretically observable peptides of a specific protein and they have been shown to correlate 
with the absolute protein amount in the samples (Schwanhäusser et al., 2011). Due to the 
different expression of GFP-tagged H2A variants, all replicates were normalized using largely 
unmodified peptides of histone H4.  A protein was considered to be chromatin-bound when 
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its average log2 transformed iBAQ value showed a difference of at least 3.5 between the 
GFP-H2A variant sample and the background control (noGFP). The samples were further 
filtered excluding all the proteins that were identified only in one experiment. The enrichment 
factors were used to evaluate how the proteome of the chromatin containing GFP-tagged 
histone variants varies among the pull downs. This was obtained by calculating the log2 
enrichment of the ratio between the enrichment factors of different GFP-tagged histone 
variants pull downs (Figure 4.8 A). The values obtained for every protein were displayed on a 
scatter plot (Figure 4.8 B). 
 
 
Figure 4.8 Chromatin containing the GFP-tagged histone variants shows different protein composition. 
(A) Schematic representation of the mass spectrometry data analysis workflow. (B) Proteomic analysis of GFP-
H2A.Bbd, GFP-macroH2A.1.2 and GFP-H2A containing chromatin. Specific proteins enriched in the GFP-
H2A.Bbd pull down over the proteins in the GFP-macroH2A.1.2 (x-axis) and GFP-H2A (y-axis) pull downs are 
displayed in a scatter plot according to their log2 enrichment values. 
 
Consistent with the observation that H2A.Bbd and macroH2A.1.2 show a very different 
localization pattern, the proteomic profile of the chromatin containing their GFP-tagged 
version turned out to be very divergent. 
 
As there is not so much knowledge about the effects of H2A.Bbd on chromatin structure and 
its molecular function, the subsequent analysis focused on the protein factors enriched in the 
GFP-H2A.Bbd sample. Due to the large number of protein enriched in the chromatin 
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containing GFP-H2A.Bbd, Gene Ontology (GO) analysis was performed to understand 
whether there are particular functional categories overrepresented. The GO analysis of the 
proteins enriched in the GFP-H2A.Bbd compared to the GFP-macroH2A.1.2 containing 
chromatin revealed the presence of several factors involved in splicing regulation and mRNA 
processing (Appendix Table I). This is consistent with the recent discovery that H2A.Bbd 
might play a role in RNA splicing (Tolstorukov et al., 2012).  
 
In addition, several proteins involved in the replication process were enriched in the GFP-
H2A.Bbd compared to the GFP-macroH2A.1.2 and GFP-H2A containing chromatin 
(Appendix Table I). Among those some revealed a very high enrichment factors, such as the 
proliferating cell nuclear antigens (PCNA), the facilitates chromatin transcription complex 
(FACT), the chromatin assembly complex 1 (CAF1) and some components of the mini 
chromosome maintenance complex (MCM) (Table 4.1). Some of these proteins are also 
enriched when comparing GFP-H2A.Bbd chromatin with chromatin isolated from cells 
expressing GFP-H2A, suggesting that they are specific for GFP-H2A.Bbd rather than 
excluded from chromatin that contains GFP-macroH2A.1.2 (Appendix Table II). Interestingly, 
there is one protein factor that showed a very high and significant enrichment in the 
chromatin containing GFP-H2A.Bbd. Its name is Protein Phosphatase 1G (Ppm1G) and it was 
shown to be a putative chaperone for the H2A-H2B dimers (Kimura et al., 2006) (Table 4.1). 
Protein names 
log2 enrich. 
bbd/h2a 
samples 
p-value 
log2 enrich. 
bbd/macro 
samples 
p-value 
Fin13;Ppm1g 18.9 0.0004 17.53 0.0005 
Pcna 9.26 0.006 9.03 0.004 
Gins1 7.42 0.02 5.8 0.03 
Mcm3 5.44 0.29 4.84 0.27 
Cdc21;Mcm4 -1.04 0.48 0.09 0.96 
Cdc46;Mcm5 0.25 0.97 6.21 0.17 
Cdc47;Mcm7 1.17 0.75 2.63 0.27 
Mcm6 0.86 0.92 3.21 0.47 
Ssrp1 4.31 0.18 10.13 0.01 
Fact140 5.35 0.15 9.86 0.02 
Chaf1b 7.02 0.09 5.98 0.10 
Rbbp4 2.56 0.61 3.46 0.36 
Table 4.1 Replication associated factors are enriched in the chromatin containing GFP-H2A.Bbd. 
Enriched replication factors in the GFP-H2A.Bbd containing chromatin are displayed according to their 
enrichment factors and p-values calculated in the GFP-H2A.Bbd over GFP-H2A and in the GFP-H2A.Bbd over 
GFP-macroH2A.1.2 samples. 
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In contrast to GFP-H2A.Bbd, the chromatin containing GFP-macroH2A.1.2 showed an 
enrichment of factors involved in transcriptional repression and heterochromatin formation  
(Table 4.2). So are, for example, two components of the Polycomb Repressive Complex 2 
(PRC2), EED and EZH2 significantly enriched in the GFP-macroH2A.1.2 purified chromatin. 
Interestingly, also the components of the Polycomb Repressive Complex 1 (PRC1), CBX8 
and BMI1 and the methyltransferase SUV39 were identified and enriched in the GFP-
macroH2A.1.2 chromatin.  
Protein names 
log2 enrich. 
bbd/h2a 
samples 
p-value 
log2 enrich. 
bbd/macro 
samples 
p-value 
Eed -7.37 0.00494 -8.45 0.003 
Ezh2 -10.26 0.00095 -7.86 0.002 
Cbx8 -6.14 0.58 -5.31 0.548 
Suv39h1 -5.49 0.51 -6.36 0.334 
BmI1 0.59 0.86 -3.31 0.108 
Table 4.2 GFP-macroH2A.1.2 containing chromatin is enriched in heterochromatic factors. 
Enriched factors in the GFP-macroH2A.1.2 containing chromatin are displayed according to their enrichment 
factors and p-values calculated in the GFP-H2A.Bbd/GFP-macroH2A.1.2 and in the GFP-H2A.Bbd/GFP-H2A 
samples. 
 
Taken together the mass spectrometry results confirmed that the histone variants H2A.Bbd 
and macroH2A.1.2 are incorporated at different chromatin domains marked by specific 
protein factors and complexes. Consistent with the current literature, showing that H2A.Bbd 
is detected preferably at sites of alternative splicing, the analysis showed a strong enrichment 
of factors that play a role in RNA metabolism. As expected from its nuclear localization and 
in contrast to GFP-H2A.Bbd, GFP-macroH2A.1.2 associates with repressive chromatin. 
Moreover, the proteomic analysis of the chromatin containing GFP-H2A.Bbd revealed an 
interesting connection of this variant with factors involved in the replication process.  
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4.4 Histone modification analysis of chromatin containing GFP-tagged histone 
H2A.Bbd and macroH2A.1.2 
As the proteomic analysis of the GFP-H2A.Bbd and GFP-macroH2A.1.2 containing 
chromatin showed significant differences in the protein composition, it was further 
hypothesized that the histone modifications patters of the purified chromatin fibres could also 
reveal interesting differences.  
MacroH2A is incorporated at sites where the repressive mark H3K27me3 is highly enriched 
(Costanzi and Pehrson, 1998). In contrast, H2A.Bbd was first discovered to be present at H4 
hyperacetylated loci (Chadwick and Willard, 2001a). To test whether the chromatin fibres 
containing GFP-H2A.Bbd and GFP-macroH2A.1.2 displayed distinct histone modifications 
patterns, the histone H3 and H4 bands were cut out of the Coomassie gel after chromatin 
GFP-affinity purification and processed for histone modifications analysis.  
To understand whether particular modifications could be specifically enriched in the 
chromatin containing GFP-H2A.Bbd and GFP-macroH2A.1.2, the histone H3 and H4 were 
also analyzed for the chromatin containing GFP-H2A. The analysis was performed in 
collaboration with Teresa Barth. 
 
The histone modifications found in the chromatin purified fractions showed different 
enrichment levels from the background histone fractions represented by the histones that bind 
the GFP-trap beads, providing further evidences that the samples are constituted by specific 
chromatin domains associated to the tagged histone variants. 
Particular attention was given to the peptide derived from the amino acids 27 to 40 and 9 to 
17 of H3 that contain the repressive marks H3K27me3 and H3K9me3. According to the 
literature and to the proteomic data that showed an enrichment of the PRC2 complex and 
SUV39 enzyme, these two modifications were expected to be enriched on the chromatin 
fibres containing GFP-macroH2A.1.2. However, no particular enrichment for H3K27me3 and 
H3K9me3 was observed in the GFP-macroH2A.1.2 compared to GFP-H2A.Bbd containing 
chromatin (Figure 4.9 A-B). 
 
H2A.Bbd was previously shown to colocalize with H4 hyperacetylated loci (Costanzi and 
Pehrson, 1998). However, the analysis of the modification of H4 present in the chromatin 
containing GFP-H2A.Bbd did not show any particular enrichment of acetylation compared to 
the H4 present in the GFP-macroH2A.1.2 and GFP-H2A containing chromatin (Figure 4.9 C). 
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The proteomic analysis of the chromatin containing specific GFP tagged histone variants 
revealed an interesting enrichment of factors involved in the replication process associated 
with GFP-H2A.Bbd indicating the presence of replicating chromatin in the sample (Table 2.9). 
To determine whether the enrichment of replicating chromatin in the GFP-H2A.Bbd sample 
could also result in a different H3.1/H3.3 ratio, the levels of H3.1 and H3.3 were further 
quantified. However, no differences were detected in the H3.1/H3.3 levels in the purified 
chromatin containing the three GFP-tagged variants (Figure 4.9 D). 
In conclusion, despite the different nuclear localization and mutual chromosomal exclusion of 
H2A.Bbd and macroH2A, chromatin fibres containing the GFP tagged histone variants 
showed similar distribution of the histone modifications. However, the analyzed histones 
seem to be specific for the purified chromatin as they show clear differences when compared 
to the histones bound to the GFP-trap beads.  
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Figure 4.9 Chromatin containing the GFP-tagged histone variants H2A.Bbd, macroH2A.1.2 or H2A does 
not show any enrichment for particular histone variants. 
A) Modifications percentage of H3 peptide 27 to 40 B) Modifications percentage for the histone H3 peptide 9 to 
17 C) Modification percentage for the histone H4 peptide 4 to 17 D) Ratio between the level of H3.1 and H3.3 
after GFP chromatin purification. 
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4.5 H2A.Bbd localizes at replication foci during S-phase 
Ishibashi and colleagues described a particular localization pattern in a mouse embryonic cell 
line that expressed tagged-H2A.Bbd. In those cells, they detected a ‘dotty pattern’ where 
H2A.Bbd was co-localizing with DNA dense regions (Ishibashi et al., 2010). Interestingly, a 
fraction of MEF cells expressing GFP-H2A.Bbd generated for this project showed the same 
localization pattern described above (Figure 4.10). 
 
 
Figure 4.10 H2A.Bbd co-localizes with DNA-dense regions in a sub-population of cells expressing GFP-
H2A.Bbd. 
Single confocal slice of asynchronous population of female MEF cells that express GFP-H2A.Bbd. To-PRO: 
DNA (blue); GFP: GFP-H2A.Bbd (green). The arrow indicates GFP-H2A.Bbd co-localizing with DNA dense 
regions. The two panels represent different areas of acquisition. Scale bar upper panel: 5 µm; lower panel: 10 µm. 
 
Together with the mass spectrometry results, that showed an enrichment of replication- 
associated factors in chromatin containing GFP-H2A.Bbd, the co-localization with DAPI 
dense regions suggested a possible replication coupled incorporation of GFP-H2A.Bbd. To 
test whether the MEF cells that show the co-localization of GFP-H2A.Bbd with the DAPI 
dense regions are in S-phase, an asynchronous population of cells was labeled with 5-ethynyl-
2’-deoxyuridine (EdU) for 30 minutes to visualize sites of DNA synthesis in proliferating 
cells (Salic and Mitchison, 2008). This experiment revealed that the cells that showed the 
‘dotty pattern’ were cells in S-phase (Figure 4.11).  
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Figure 4.11 H2A.Bbd localizes at sites of replication during all stages of the S-phase. 
Single confocal slice of female MEFs expressing H2A.Bbd labeled with EdU and stained with anti-GFP at 
different time of replication. EdU: replication foci (red); GFP-H2A.Bbd: GFP (green); DAPI: DNA (blue). Early 
S-phase: eS; late S-phase: lS. Scale bar: 5 µm. 
 
Co-localization of GFP-H2A.Bbd and EdU is observed throughout S phase exhibiting the 
expected distribution pattern in early replicating (eS) and late replicating chromatin (lS) 
described for mammalian cells (Figure 4.11) (Chakalova et al., 2005). Outside S-phase the 
GFP-H2A.Bbd, as well as the GFP-macroH2A.1.2 and the GFP-H2A signals are distributed 
all over the nucleus without any particular pattern (data not shown).  
 
To better understand the dynamics of the GFP-H2A.Bbd incorporation at sites of replication, 
an asynchronous MEF cells expressing GFP-tagged H2A.Bbd, macroH2A.1.2 and H2A were 
labeled for 30 minutes with EdU. First the cells were fixed immediately after EdU labeling  
(Figure 4.12 A-B).  
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Figure 4.12 H2A.Bbd localizes at sites of DNA synthesis during replication. 
(A) Single confocal slice of female early- replicating MEFs expressing the GFP-tagged histone variants pulsed 
labeled with EdU. (B) Single confocal slice of late-replicating MEFs expressing the GFP-tagged histone variants 
pulsed labeled with EdU. DAPI: DNA (blue); GFP: GFP-tagged histone variant (green); EdU: replication foci 
(red). Scale bar: 5 µm. 
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The analysis of the channel intensities revealed that only GFP-H2A.Bbd shows a very strong 
co-localization with the EdU labeled sites suggesting that this histone variant is recruited to 
sites of DNA replication (Figure 4.13 A-B).  
 
 
Figure 4.13 GFP-H2A.Bbd, but not GFP-macroH2A.1.2 or GFP-H2A, co-localizes with DNA replication 
foci during S-phase. 
(A) The channels intensity recorded in early replicating cells along the white line is plotted on a diagram. Blue 
line: DNA; green line: GFP-tagged histone variants; red line: replication foci. (B) The channels intensity 
recorded in late- replicating cells along the white line is plotted on a diagram. Blue line: DNA; green line: GFP-
tagged histone variants; red line: replication foci. Scale bar: 5 µm. 
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Histone variants have been already shown to localize at sites of DNA synthesis sites (Polo et 
al., 2006). However, such a strong co-localization with DNA replication has not been 
observed so far. Moreover, the incorporation of GFP-H2A.Bbd is visible during different 
stages of the S-phase suggesting that the histone variant follows the replication process.  
 
The next question was whether the incorporation of GFP-H2A.Bbd at replication foci is 
stably maintained after the replication machinery moves on or whether GFP-H2A.Bbd is 
removed from sites of DNA replication. To address this point an asynchronous population of 
MEF cells was pulse for 30 minutes with EdU and then chased for 1h before fixation. After 
1h chase the GFP-H2A.Bbd expressing MEF cells did not show the co-localization of the 
histone variant with the newly replicated DNA anymore (Figure 4.14 A-B). 
 
The analysis of the channels intensity confirmed that GFP-H2A.Bbd is no longer co-
localizing with the EdU signal after 1h chase but is rather neighboring the EdU labeled DNA 
(Figure 4.15 A-B). This is particularly evident in the late- replicating cells (Figure 4.15 B), 
suggesting that GFP-H2A.Bbd incorporation follows the replication process. 
 
  
Results 
 43 
 
Figure 4.14 H2A.Bbd localizes at sites of DNA synthesis during replication and is removed within 1h. 
(A) Single confocal slice of female early- replicating MEFs expressing the GFP-tagged histone variants pulsed 
labeled with EdU and chased for 1h. (B) Single confocal slice of late-replicating MEFs expressing the GFP-
tagged histone variants pulsed labeled with EdU and chased for 1h. DAPI: DNA (blue); GFP: GFP-tagged 
histone variant (green); EdU: replication foci (red). Scale bar: 5 µm. 
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Figure 4.15 GFP-H2A.Bbd is removed from sites of DNA synthesis within 1h during replication. 
(A) The channels intensity recorded in early replicating cells along the white line is plotted on a diagram. Blue 
line: DNA; green line: GFP-tagged histone variants; red line: replication foci. (B) The channels intensity 
recorded in late- replicating cells along the white line is plotted on a diagram. Blue line: DNA; green line: GFP-
tagged histone variants; red line: replication foci. Scale bar: 5 µm. 
 
All together these results show that GFP-H2A.Bbd is incorporated into chromatin during 
replication. The incorporation of GFP-H2A.Bbd during replication is not stable, but the 
tagged histone variant is removed within 1h. 
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4.6 GFP-H2A.Bbd follows PCNA at replication foci 
One interesting protein identified and enriched in the GFP-H2A.Bbd chromatin affinity 
purification was the Proliferating Cell Nuclear Antigen (PCNA). 
PCNA is a DNA polymerase cofactor during the replication process. It adopts a ring-shape 
structure and encircles the replicated DNA strand. The presence of PCNA at the replication 
foci is the key event for the association of the replicative polymerases to the DNA strands. 
Moreover, PCNA enhances the processivity of the polymerases enzymes and is a binding 
platform for many proteins involved in the replication process (Moldovan et al., 2007). 
To investigate whether H2A.Bbd is following the replication fork we looked at live cell 
imaging using MEFs expressing GFP-H2A.Bbd co-transfected with an mRFP-PCNA. The 
following experiment was performed in collaboration with Dr. Corella Casas Delucchi. By 
following the mRFP-PCNA during replication it is clear that GFP-H2A.Bbd is recruited after 
PCNA at the replication foci (Figure 4.16). 
 
 
Figure 4.16 H2A.Bbd follows PCNA at replication foci. 
Selected frames of time-lapse imaging of MEF cells stably expressing GFP-H2A.Bbd (green) transfected with 
mRFP-PCNA (red). Z-stacks were collected every 20 min over night using a spinning disk microscope equipped 
with temperature, humidity and CO2 control. Shown are maximum intensity projections. 
 
  
Results 
 46 
 
4.7 H2A.Bbd is recruited at DNA damage sites after microirradiation 
PCNA is not only involved in DNA replication, but also plays an important role in DNA 
repair (Moldovan et al., 2007). The recruitment of GFP-H2A.Bbd to replication foci 
following PCNA suggested that GFP-H2A.Bbd could be also recruited to sites of DNA 
damage. To test this hypothesis, microirradiation experiments were performed in 
collaboration with Dr. Corella Casas Delucchi. 
MEF cells expressing GFP-H2A.Bbd were microirradiated and GFP-H2A.Bbd recruitment 
was monitored in live imaging cells. Different frames of a live cell imaging movie were 
selected and clearly show that GFP-H2A.Bbd is recruited at sites of DNA damage after 
microirradiation (Figure 4.17). It is interesting to notice that when recruited at DNA damage 
sites, GFP-H2A.Bbd signal is still detectable after 110 minutes post-irradiation in contrast to 
its fast replacement during replication. 
 
 
Figure 4.17 H2A.Bbd accumulates at DNA damage sites following PCNA. 
Time-lapse imaging of microirradiated MEF cells stably expressing GFP-H2A.Bbd (green) and transfected with 
mRFP-PCNA (red) at 405 nm for 1200 ms. Images were collected before microirradiation and 5 seconds, 10/50 
and 110 minutes after microirradiation. Scale bars: 5 µm. 
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4.8 MEF cells expressing GFP-H2A.Bbd have a shorter S-phase and are more 
sensitive to DNA damage 
The association of GFP-H2A.Bbd to replication and DNA damage questioned whether its 
recruitment could have an effect on the S-phase length or DNA damage sensitivity. To test 
whether the localization of GFP-H2A.Bbd at replication and DNA damage loci has an effect 
on replication and sensitivity to damage, the doubling time and the S-phase time were 
measured in MEF cells expressing GFP-H2A.Bbd and GFP-H2A. These measurements were 
obtained in collaboration with Malini Rajan. This analysis demonstrated that MEF cells 
expressing GFP-H2A.Bbd have a shorter doubling time and a shorter S-phase compared to 
the MEF cells expressing GFP-H2A (Figure 4.18 A). 
Moreover, the analysis of the Cyclobutane Pyrimidine Dimers (CPD), which indicates the 
level of DNA damage in UV treated cells, shows a higher sensitivity to DNA damage in GFP-
H2A.Bbd compared to GFP-H2A expressing MEF cells 30 minutes after irradiation (Figure 
4.18 B).  
 
 
Figure 4.18 MEF cells expressing H2A.Bbd replicate faster and are more sensitive to DNA damage. 
(A) Doubling time and S-phase length in MEF cells stably expressing GFP-H2A.Bbd and GFP-H2A. (B) Mean 
intensity of nuclear CPD signal 10 and 30 minutes post 1mJ UVC irradiation. Error bars represent the 95% 
confidence interval. N>30. 
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4.9 H2A.Bbd expression in Hodgkin’s Lymphoma cell lines 
Under physiological conditions H2A.Bbd is only expressed in testis and to a lower extent in 
brain (Chadwick and Willard, 2001a; Ishibashi et al., 2010). This particular expression pattern 
suggested a specific role of H2A.Bbd during spermatogenesis. Interestingly, there is a special 
class of genes that are expressed in testis and silent in other tissues, which become re-
activated in different cancer types. These genes are classified as Cancer Testes Antigens 
(CTA) (Cheng et al., 2011). Recently, a microarray based screening for new CTAs in 
Hodgkin’s Lymphoma cells revealed that H2A.Bbd could indeed be a new potential CTA 
gene (Winkler et al., 2012). In collaboration with Dr. Martin Staege the expression levels of 
H2A.Bbd were measured in five Hodgkin’s Lymphoma cell lines by qPCR. H2A.Bbd is 
indeed expressed in these cell lines with different expression levels (Figure 4.19 A). The 
H2A.Bbd protein levels were measured by Western Blotting using nuclear extracts from five 
different Hodgkin’s Lymphoma cell lines. As control EBV-immortalized B-cell lines, LCL2 
and EBV1.11, were used. Interestingly, H2A.Bbd protein can be detected in at least four out 
of five Hodgkin’s Lymphoma cell lines with different expression levels confirming the results 
obtained in the mRNA analysis (Figure 4.19 B). 
When the doubling time of the Hodgkin’s Lymphoma cells lines reported in (Drexler et al., 
2010) was compared to the level of H2A.Bbd expression in Figure 4.19 A, an interesting 
correlation was found between the time of replication and the expression levels. In summary, 
the cells that express the higher levels of H2A.Bbd, such as the L428 or the L1236, replicate 
faster whereas the cell line that show lower level of expression, i.e. the L540 and the HDLM-
2, are slower in doubling (Figure 4.19 C). 
Taken together these results show for the first time that H2A.Bbd protein is abnormally 
expressed in Hodgkin’s Lymphoma cell lines and that the level of expression correlates with 
their replication time. 
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Figure 4.19 H2A.Bbd is expressed in Hodgkin's Lymphoma cell lines. 
(A) rRT-PCR expression analysis of H2A.Bbd in HL cell and control cell lines. cDNA from HL cell line (2 
independent experiments and normal PBMC (21 donors) was used for quantitative PCR. For calculation of 
relative expression values, actin beta was used as housekeeping control and the median expression in normal 
PBMC was set as 1. (B) Western blot analysis of H2A.Bbd in Hodgkin’s lymphoma cells (HL) and control cell 
lines. Ponceau staining of the histone H3 is used as loading control. (C) Dot plot showing the correlation in 
Hodgkin’s Lymphoma cell lines between the doubling time derived from (REF) (y-axis) and the expression 
levels of H2A.Bbd (x-axis_ measured by qRT-PCR). Every dot represents a specific Hodgkin’s Lymphoma cell 
lines.  
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5 Discussion 
Chromatin is regulated in distinct ways including the addition or removal of specific histone 
modifications and the recruitment of specific protein factors that read and erase the histone 
modifications. In addition, the histone variants play a significant role in the regulation of 
chromatin accessibility by modulating the nucleosome structure and consequently the higher 
order chromatin structure. However, in recent years, the role of the histone variants in 
different cellular processes has been addressed mainly by looking at their effects on the 
nucleosome stability or their association to specific DNA sequences.  
 
The main aim of this work was to better define the function of the histone variants H2A.Bbd 
and macroH2A in the light of the protein environment they are in. To achieve this, specific 
chromatin domains containing the GFP-tagged histone H2A.Bbd and macroH2A.1.2 were 
purified and their proteomic profile was analyzed using mass spectrometry.   
After analyzing the possible reason why it was not possible to achieve comparable levels of 
expression for the three GFP-tagged histone variants, the discussion will mainly focus on the 
results obtained from the proteomic analysis of the GFP-tagged histone containing chromatin. 
These experiments revealed remarkable differences in the protein composition of the two 
‘types’ of chromatin containing the tagged histone variants. The presence of specific 
heterochromatic or euchromatic factors and their putative link with the histone variant 
H2A.Bbd and macroH2A.1.2 will be further explored in this section.  
 
Moreover, this study also revealed new, interesting features of H2A.Bbd. Indeed it was shown 
for the first time that GFP-H2A.Bbd ectopically expressed in MEF cells localizes to sites of 
DNA synthesis during replication and DNA repair. Due to its tissue-specific expression, it is 
unlikely that H2A.Bbd could play a role in somatic cell during DNA replication and repair, 
but this new finding is particularly relevant and will be further discussed in the light of the 
H2A.Bbd expression detected in Hodgkin’s Lymphoma cell lines. The effects on DNA 
damage sensitivity observed in MEF overexpressing GFP-H2A.Bbd will be also used to 
decipher the possible role that H2A.Bbd could have in testis, where it is normally expressed 
during male germ cells differentiation.   
In summary, this study not only provided new evidences about the importance of the histone 
variants in chromatin regulation but also opened new questions about the role of H2A.Bbd in 
cancer and spermatogenesis. 
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5.1 Potential negative effect of macroH2A.1.2 expression in MEF cells 
To study the proteomic composition of the chromatin containing the histone variants 
H2A.Bbd and macroH2A.1.2, MEF cells were transfected with GFP tagged H2A.Bbd and 
macroH2A.1.2. Thereafter, single cell clones expressing the GFP-tagged histones were 
isolated from the transfected MEFs by FACS sorting. 
Interestingly, the first three single cell clones selected for GFP-macroH2A.1.2 lost the 
expression of the GFP tagged variant after some consecutive weeks in culture. The population 
derived from six sorted cells maintained the expression of GFP-macroH2A.1.2 in most of the 
cells resulting in a low expression level compared to the MEF cells expressing GFP-H2A.Bbd 
and GFP-H2A (Figure 4.1 B). It is not possible to exclude that the repression of the 
exogenous gene is the result of a technical problem such as the CpG content of the construct.  
 
However, one intriguing hypothesis is that the MEF cells expressing GFP-macroH2A.1.2 do 
not allow high levels of the exogenous gene expression. This would explain the failure in 
achieving the same expression levels for all the GFP-tagged histone variants and the 
repression observed in the first three single cell clones. In support of this hypothesis, 
increasing evidence points towards a repressive role of macroH2A in cancer progression 
(Cantariño et al., 2013). In fact, macroH2A.1.1 was found up-regulated in tumors that show a 
low mitotic index, whereas tumors with higher mitotic indices displayed low expression of 
this histone variant. This suggests the role of macroH2A.1.1 as a tumor-suppressor (Sporn et 
al., 2009). MacroH2A.1.2 function in tumorigenesis in contrast appears to be more context-
dependent. Up-regulation in melanoma cells, for example, leads to a reduced metastatic 
potential (Kapoor et al., 2010), whereas in breast cancer, high levels of macroH2A.1.2 
promoted cell growth, invasion and migration (Dardenne et al., 2012; Li et al., 2012). 
Viewed together, these findings suggest that macroH2A.1.2 overexpression decreases the 
proliferative potential of MEF cells. Extended passaging of GFP-macroH2A.1.2 transfected 
MEFs may therefore enrich for cells with lower expression level. 
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5.2 GFP tagged H2A.Bbd and macroH2A.1.2-containing chromatin domains 
show differences in their proteomic profile 
After chromatin affinity purification, the identification of the chromatin-bound proteins 
revealed an obvious difference in the number of proteins present in the respective H2A 
variant specific chromatin. However, also the biological replicates only showed a partial 
overlap (Figure 4.7). It is important to mention that the samples were measured in the mass 
spectrometer at different times. This could in part explain the variability observed among the 
replicates. In fact, many studies have been dedicated to increase the reproducibility of mass 
spectrometry datasets acquired on affinity purification samples. The most recent studies point 
to the importance of reducing the sample variability by using the same sample treatment, 
machines and conditions (Dazard et al., 2012; Varjosalo et al., 2013). Remarkably, increased 
sample variability may have also resulted from the use of native/unfixed chromatin because 
the abundance of proteins that displayed weak or transient interactions with the bait might be 
sometimes below the sensitivity of detection. Considering these technical issues, if only the 
proteins present in all the three replicates are considered as specific chromatin interactors, 
novel, interesting interactions might be discarded. Therefore, the quantification was 
performed using proteins present in at least two biological replicates. Using these criteria, the 
overlap reached an average of 50% in every GFP-H2A variant chromatin purification. 
 
As mentioned above, the samples revealed an obvious difference in the number of identified 
proteins, with the GFP-H2A.Bbd containing chromatin having a higher number of entries 
compared to the GFP-macroH2A.1.2 chromatin. One of the possible explanations for this 
marked difference could be the clear expression level discrepancy observed in the MEF cell 
expressing GFP-H2A.Bbd and GFP-macroH2A.1.2 (Figure 4.1 B). To avoid that the 
expression levels differences could affect the quantification of the protein present in the 
purified chromatin, all the samples were normalized to the level of H4. 
After statistical analysis, the two samples that showed relevant differences were the GFP-
H2A.Bbd and GFP-macroH2A.1.2 purified chromatin samples. This result reflects the 
specific and mutual exclusive nuclear localization of the two variants ((Chadwick and Willard, 
2001a; Costanzi and Pehrson, 1998) and Figure 4.2) 
It is worth noting that the different chromatin composition can not be explained by major 
differences in the canonical histone composition, which do not show particular variation, but 
rather in the presence of the histone variants H2A.Bbd and macroH2A.1.2 thus supporting the 
important role that the histone variants play in chromatin regulation and gene expression. 
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5.3 Proteomic profile of GFP-macroH2A.1.2 
MacroH2A is a large H2A variant characterized by a non-histone macro domain that serves as 
a binding module for NAD metabolites (Kustatscher et al., 2005). MacroH2A has been 
extensively studied in recent decades for its role in the late stages of the X chromosome 
inactivation that pointed to a repressive role for macroH2A in transcription regulation 
(Costanzi and Pehrson, 1998). However, the presence of macroH2A in species that do not 
undergo X inactivation and, in addition, the similar expression of macroH2A in male and 
female, suggested that this histone variant could be implicated in the regulation of processes 
outside X inactivation (Buschbeck and Di Croce, 2010; Rasmussen, 1999).  
Several studies attempted to elucidate the role of macroH2A in gene expression but the more 
evidence obtained the more difficult it became to give macroH2A one unique function in 
transcription regulation. It is now clear that macroH2A functions are basically context-
dependent and that it is important to discriminate among the two macroH2A genes, 
macroH2A.1 and macroH2A.2, and isoforms, macroH2A.1.1 and macroH2A.1.2. In this 
context, the identification of putative chromatin binding factors that surround the macroH2A 
containing chromatin has become relevant. 
 
When comparing the proteins present in the GFP-macroH2A.1.2 chromatin together with 
those present in the GFP-H2A.Bbd samples, a striking enrichment of factors associated with 
repression of transcription was found (Table 4.2). 
In particular, some of the Polycomb Repressive Complex 2 (PRC2) factors showed significant 
enrichment in the GFP-macroH2A.1.2 containing chromatin. This result confirmed previous 
data that showed an overlap between macroH2A and PRC2 binding regions (Buschbeck et al., 
2009). Despite the striking enrichment of the PRC2 complex in the GFP-macroH2A.1.2 
containing chromatin, the analysis of the histone modifications did not reveal any particular 
enrichment for the H3K27me3, which is generally known to be placed by the PRC2 complex 
(Margueron and Reinberg, 2011). The presence of the PRC2 complex and the absence of the 
H3K27me3 enrichment would suggest that not all the nucleosomes bound by the Polycomb 
carry the H3K27me3 modification. This would involve the presence of an alternative form of 
the PRC2 complex at specific loci not engaged in setting this modification. Interestingly, 
recent studies demonstrate the presence of the PRC2 complex at sites that are not enriched for 
H3K27me3. In Xenopus it has been shown that the presence of the PRC2 complex does not 
correlate with the presence of H3K27me3 at defined stages during development (van 
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Heeringen et al., 2014). In mouse embryonic stem cells (ESC), the PRC2 complex bound to 
TSSs can be repressed by nascent transcript and this results in the absence of H3K27me3 
(Kaneko et al., 2013). In essence, the data support the overlap between the PRC2 complex 
and the histone variant macroH2A.1.2 already observed by others but has raised new 
questions about the PRC2 complex and its role in modifying the histone H3 on lysine 27. 
 
Together with the PRC2, the PRC1 complex is also enriched in the GFP-macroH2A.1.2 
containing chromatin (Table 4.2). In this study, one of the subunits found particularly 
enriched in the sample is the Chromobox homolog 8 (CBX8). The presence of CBX8 in the 
chromatin containing GFP-macroH2A.1.2 is very intriguing and it could be related to the 
putative role that macroH2A plays in cell senescence. CBX8 is a chromodomain containing 
protein, which was first characterized as a component of the PRC1 complex that associates 
with BMI1 repressing transcription (Bárdos et al., 2000). Further investigations showed that 
CBX8 repressed the INC4A/ARF locus regulating the proliferation of mouse and human 
fibroblasts and the senescence process (Dietrich et al., 2007). Interestingly, macroH2A has 
been found to repress Cdkn2a/p16 (INK4A) in colorectal cancer cell line leading to an 
enhanced proliferation (Barzily-Rokni et al., 2011). In summary, the data from the GFP-
macroH2A.1.2 chromatin purification provide new evidences that these two proteins could 
interplay in the regulation of particular genes that are targeted by the CBX8 containing PRC1 
complex. 
 
Another factor associated with repression of transcription, which is present in the 
macroH2A.1.2 containing chromatin, is the methyltransferase SUV39h1 (Table 4.2). This 
suggests that pericentric heterochromatin is also recovered in these purifications. The 
presence of macroH2A at pericentric heterochromatin has already been reported, but only 
upon chromatin reorganization induced by nuclear transplantation or DNA hypomethylation 
(Pasuq v. et al., 2011; Ma Y et al., 2005). It would be possible that only a small fraction of the 
histone macroH2A is present at pericentric heterochromatin. This would also explain why 
there is no evident enrichment of H3K9me3 in the GFP-macroH2A.1.2 containing chromatin.  
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5.4 Proteomic profile of GFP-H2A.Bbd 
Mass spectrometry analysis showed particular differences between the chromatin factors 
associated with GFP-H2A.Bbd and GFP-macroH2A.1.2.  As of yet there is little information 
about putative direct or indirect interaction partners of H2A.Bbd. Recently, it was shown that 
in HeLa cells GFP-H2A.Bbd is incorporated in chromatin enriched for splicing factors 
suggesting a putative role of H2A.Bbd in the regulation of the splicing process (Tolstorukov 
et al., 2012). In keeping with this, the analysis of the chromatin containing GFP-H2A.Bbd 
showed an enrichment of factors involved in splicing regulation and mRNA processing, 
partially overlapping with the previous report (Appendix Table I and II). 
In addition, DNA replication was also found as an overrepresented category in the GFP-
H2A.Bbd containing chromatin compared to the GFP-macroH2A.1.2 containing chromatin 
(Appendix Table I)).  This category comprised members of the DNA replication initiation 
complex such as the MCM proteins and the GINS, and factors involved in the replication 
process such as PCNA (Table 4.1). However, even if several factors involved in the 
replication process showed a high enrichment in the GFP-H2A.Bbd chromatin, the p-values 
associated with some of them are not significant. The high p-values could be explained in 
different ways. First of all the chromatin purification was performed using an asynchronous 
population of MEF cells expressing the GFP-tagged histone variant, with only a small 
fraction of cells that are actively replicating at the time of harvesting. Secondly, the 
immunofluorescence experiments revealed that the localization of GFP-H2A.Bbd at sites of 
active replication is only transient and disappears within 1h. As already mentioned all the 
experiments were performed using native chromatin, which is not the best tool to study 
transient interactions and this can influence the reproducibility of the data. 
 
H2A.Bbd was shown to localize at sites of H4 hyperacetylation (Chadwick and Willard, 
2001a). However, the histone modification analysis did not reveal any particular acetylation 
enrichment on H4 peptides compared to the GFP-macroH2A.1.2 containing chromatin. This 
apparent discrepancy could be related to the presence of large chromatin fragments that do not 
all contain the histone variant H2A.Bbd. The histone modification analysis performed on 
mononucleosomes would, perhaps, give better information about the modifications related to 
the histone variant H2A.Bbd. 
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In summary, the mass spectrometry analysis of the chromatin containing GFP-H2A.Bbd in 
part confirmed previous reports that showed a role of H2A.Bbd in RNA splicing, but also 
revealed new, interesting features and possible new interactors of this histone variant. 
 
5.5 GFP-H2A.Bbd recruitment at DNA synthesis sites during DNA replication 
and DNA repair 
GFP-H2A.Bbd is removed within 1h from the replication foci, whereas it is retained longer at 
DNA damage site (Figure 4.15 and Figure 4.17). One possibility is that the incorporation of 
GFP-H2A.Bbd at replication foci is generating unstable nucleosomes. In support of this idea 
there are several studies that showed an evident destabilization of the nucleosome containing 
H2A.Bbd compared to the canonical nucleosome (Bao et al., 2004; Eirín-López et al., 2008; 
González-Romero et al., 2008). Notably, a recent article showed that synchronized HeLa cells 
overexpressing H2A.Bbd were more sensitive during S-phase to MNase digestion compared 
to the cell overexpressing H2A (Goshima et al., 2014). This experiment is particularly 
relevant for two reasons: first, it explains why it was not possible to see a relevant variation of 
the chromatin compaction in non-synchronized cells after MNase digestion (Figure 4.5 A-B); 
second because, that H2A.Bbd needs to be removed rapidly from sites of DNA synthesis 
during replication to ensure the correct chromatin compaction. 
Goshima also showed that the overexpression of H2A.Bbd leads to cell cycle arrest and 
apoptosis (Goshima et al., 2014). In contrast here it was showed that GFP-H2A.Bbd 
overexpressing cells are replicating faster than the GFP-H2A cells. The apparent discrepancy 
of phenotypes obtained in the two studies could be explained either by the use of different cell 
types or by a dosage dependent effect of H2A.Bbd expression. In this regards it would be 
interesting to express different levels of H2A.Bbd and observe whether this brings to different 
effects on the cell cycle. 
The fast removal of GFP-H2A.Bbd from DNA replication sites could also be the reason why 
it was not possible to detect a specific enrichment of H3.1 in the chromatin containing GFP-
H2A.Bbd (Figure 4.9). 
 
As mentioned before, GFP-H2A.Bbd is rapidly removed from DNA synthesis sites during 
replication. However, after DNA microirradiation, GFP-H2A.Bbd is recruited at DNA 
damage sites following PCNA and it is still detectable after 110 min. at repair foci (Figure 
4.17). One possibility is that GFP-H2A.Bbd is simply following the dynamic of PCNA at 
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DNA damage sites. It was already shown that PCNA is engaged at least two times longer at 
sites of DNA damage than at replication foci (Essers et al., 2005). However, it would be 
interesting to test whether the presence of GFP-H2A.Bbd alters the residence time of PCNA 
at DNA damage sites compared to non-transfected cells or to the GFP-H2A expressing cells. 
 
5.6 H2A.Bbd and its putative role in spermatogenesis  
In this study, GFP-H2A.Bbd was found to localize at sites of DNA synthesis during DNA 
replication and DNA repair (Figure 4.11 and 4.17). However, H2A.Bbd is known to be a 
testis specific histone variant (Ishibashi et al., 2010) and its expression is detected at the time 
of the elongating spermatids just prior to the replacement of the canonical histone when H4 is 
highly acetylated (Ishibashi et al., 2010). The tissue and the time-specific expression of 
H2A.Bbd excludes the possibility that this histone variant could play a role in DNA 
replication and repair in somatic cells and mitotic germ cells. However, the ability of 
H2A.Bbd to be recruited at DNA synthesis sites during replication and DNA damage suggests 
that this histone variant could play a role in the replacement of the histone with protamines 
during spermatogenesis (Figure 5.1). 
 
Figure 5.1 H2A.Bbd in spermatogenesis and cancer. 
The histone variant H2A.Bbd is expressed in the elongating spermatids (ES) during spermatogenesis. The 
expression of H2A.Bbd precedes the acetylation of H4 and the DNA fragmentation, which are fundamental 
processes for the histone to protamine exchange (upper panel). The abnormal expression of H2A.Bbd in somatic 
cells may promote cancer development and progression by influencing DNA synthesis during DNA replication 
and repair (lower panel). 
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During mammalian spermatogenesis chromatin undergoes massive remodeling that leads to 
the formation of a very compacted chromatin structure required for proper spermatocytes 
formation and function (Govin et al., 2004). A key process in the context of spermatogenesis 
is the replacement of the canonical histones with protamine that ensure the proper level of 
chromatin compaction. Replacement of canonical histones by the protamines is not direct but 
involves a transition phase where several testis specific histone variants are recruited into 
chromatin (Govin et al., 2004). Immediately before replacement takes place, chromatin 
undergoes a massive wave of H4 acetylation (Meistrich et al., 1992). This event is considered 
to be the first signal for the subsequent chromatin remodeling. Moreover, during the latest 
stages of the spermatogenesis, a large number of DNA breaks are needed to ensure the 
massive chromatin remodeling and the transition from histones to protamines observed in the 
round spermatids (Marchetti and Wyrobek, 2008).  
Due to the fact that GFP-H2A.Bbd is incorporated into chromatin after DNA damage (Figure 
4.17) it is tempting to speculate that the DNA repair machinery in male germ cells could 
facilitate the incorporation of H2A.Bbd into chromatin thus promoting DNA recombination 
and protamine exchange.  
 
Unfortunately, there are no studies available that explore the role H2A.Bbd in its natural 
context during spermatogenesis. A few studies focused on its putative homologs, the four 
mouse H2A.Bbd- like proteins called H2A.Lap (lack of acidic patch) 1-4 (Soboleva et al., 
2011). Both, H2A.Bbd and its homologous in mouse H2A.Lap1, were shown to destabilize 
the nucleosome by only protecting 118 bp of DNA. In the context of spermatogenesis, the 
ability of the human H2A.Bbd and the mouse H2A.Lap1 to make the nucleosome less stable 
could be essential for the histone to protamine replacement. Indeed, H2A.Bbd and mouse 
H2A.Lap1 incorporation could favor chromatin de-compaction during the histone to 
protamine replacement. Moreover, H2A.Lap1 is enriched at the Transcription Start Sites 
(TSS) of active genes in spermatogenesis during meiosis and pot-meiotic stages (Nekrasov et 
al., 2013; Soboleva et al., 2011). The enrichment of H2A-Lap1 at the transcription start sites 
would suggest a potential role of this variant and, theoretically of H2A.Bbd, in activating 
specific genes during male germ cell line differentiation (Soboleva et al., 2011). However, it 
is important to mention that H2A.Lap1 and H2A.Bbd can not be totally functionally related as 
H2A.Lap1 gained one amino acid located in the H2A C-terminal tail α−helix responsible for 
the formation of the 30 nm fibres (Soboleva et al., 2011).  
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In this study, the most striking factor enriched in the GFP-H2A.Bbd containing chromatin is 
the Protein Phosphatase 1G (Ppm1G), also called Protein Phosphatase 2C isoform gamma 
(PP2C-gamma) or Fibroblast growth factor-inducible protein 13 (Fin13) (Table 4.1). Ppm1g 
was shown to have a high expression level in testis where H2A.Bbd is endogenously 
expressed and where the histone variant potentially plays a role (Guthridge et al., 1997). In 
addition, it was shown that Ppm1g regulates H2A/H2B exchange and there is evidence that 
this phosphatase could be involved in the regulation of the splicing process (Allemand et al., 
2007; Kimura et al., 2006). Overall, these features make Ppm1g an interesting candidate for 
further analysis to understand its relation with H2A.Bbd.  
 
Finally, the expression regulation of the testis-specific histone variants is essential for proper 
male germ cells differentiation. Here, it was shown that MEF cells overexpressing GFP-
H2A.Bbd showed higher sensitivity to DNA damage (Figure 4.18). One possible hypothesis 
is that the overexpression of H2A.Bbd in germ cell could lead to higher DNA damage 
sensitivity or defect in chromatin compaction. A similar effect was already detected in sub-
fertile patients where variable amounts of the testis-specific H2B histone variant (TSH2B) 
correlated with different level of chromatin compaction. Interestingly, the sub-fertile patients 
with higher levels of TSH2A showed s stronger Chromomycin A3 (CMA3) staining, which 
marks spermatozoa with defecting packaging (Singleton et al., 2007).  
In summary, H2A.Bbd could be essential for normal germ cell differentiation and it would be 
interesting to understand whether the overexpression of H2A.Bbd in testis could have similar 
effects to what was observed here in MEF cells.  
 
5.7 Abnormal expression of H2A.Bbd could have effects in cancer development 
Due to their important role in influencing the nucleosome structure and chromatin 
accessibility, it is intuitive to hypothesize that the de-regulation of the histone variants 
expression could affect the cellular expression profile and interfere with proper cell cycle 
regulation. 
In this respect, abnormal expression of several histone variants has been detected in different 
types of cancer. H2A.Z plays an important role in many cellular processes, such as DSBs 
repair, telomere integrity, genome stability and chromosome segregation. Its expression is de-
regulated in colorectal, lung and bladder (Dunican et al., 2002; Rhodes et al., 2004; Zucchi et 
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al., 2004). H2A.X has been defined as a ‘genome caretaker’ and tumor suppressor in defined 
genetic contexts (Vardabasso et al., 2013). The role of macroH2A has already been discussed 
in this section. All these studies underline the importance of regulating histone variant 
expression. This PhD project focused on the effects of H2A.Bbd overexpression in MEF cells 
and Hodgkin’s Lymphoma (HL) cells. Interestingly, the Hodgkin’s Lymphoma cell line tested 
for the expression of H2A.Bbd showed an inverse correlation between the levels of 
expression and the doubling time. In other words, HL cells that express high levels of 
H2A.Bbd replicate faster (Figure 4.19).  
Moreover, the MEF cells transfected with GFP-H2A.Bbd also showed higher sensitivity to 
DNA damage (Figure 4.18) and this correlates with the high sensitivity of the Hodgkin’s 
lymphoma cells to radio- and chemotherapy that has led to highly efficient cancer treatments 
(Yeoh and Mikhaeel, 2011). All these findings suggest that the abnormal presence of 
H2A.Bbd in somatic cells could be fundamental for cancer progression and development. 
 
It was previously discussed that one putative chaperone for H2A.Bbd could be the protein 
phosphatase PPM1G. This phosphatase is expressed in all tissues, but with higher levels in 
testis and it was shown to be a putative chaperone for H2A-H2B dimers (Kimura et al., 2006). 
PPM1g was found as the strongest interactor of the chromatin containing GFP-H2A.Bbd 
(Table 4.1 and Appendix Table III). It may well be that these two proteins interact in testis 
under physiological conditions and it is tempting to speculate that H2A.Bbd abnormally 
expressed in somatic cells is able to compete with H2A for the binding to PPM1g, leading to 
the preferential incorporation of H2A.Bbd-H2B dimers into chromatin. 
In summary, this study revealed new properties of the testis specific histone variants 
H2A.Bbd and opened new questions about its role in spermatogenesis and cancer 
development (Figure 5.1). Future experiments are required to investigate the way in which 
H2A.Bbd is incorporated into chromatin, and to better understand the consequences of its 
incorporation in chromatin assembly and maturation after DNA replication and repair. 
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6 Materials and Methods 
6.1 Materials 
6.1.1 Technical devices 
Description  Supplier 
MoFlo cell sorter  Beckman Coulter 
FACSCanto  Beckton Dickinson 
Ultimate 3000 HPLC  LC Pachings Dionex 
LTQ Orbitrap mass spectrometer Thermo Fisher Scientific 
LMS 510 confocal microscope Zeiss 
TCS SP5 confocal microscope Leica 
 
6.1.2 Antibodies      
Description Dilution Supplier 
a) Western Blot primary antibodies   
Mouse anti-GFP 1:1000  Roche  
Rabbit anti-H3 1:5000 Abcam 
Rabbit anti-H2A.Bbd 1:1000 Millipore 
b) Western Blot secondary antibodies  
HRP-couples secondary antibodies 1:5000   
Licor anti-rabbit 1:10000 Licor 
Licor anti-mouse 1:10000 Licor 
c) Immunofluorescence primary antibodies  
anti-H3K27me3 1:1000 Gift of Gunnar Schotta 
anti- GFP 1:200 Roche 
d) Immunofluorescence secondary antibodies  
donkey anti-mouse Alexa 488 1:1000 Jackson Immuno Research 
goat anti- rabbit Cy3 1:300 Millipore 
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6.1.3 DNA staining 
Topro 1:1000 Invitrogen 
DAPI  Vectashield 
 
6.1.4 Kits and enzymes 
Descriprion  Supplier 
MNase  Sigma 
Trypsin  Sigma 
ProteinaseK  Gennaxxon 
RNaseA  Roche 
Click-it kit  Invitrogen 
Benzonase  VWR 
 
6.1.5  Cell culture media    
DMEM  Sigma 
RPMI 1640/GlutaMAX  Gibco 
Penicillin/streptomicyn  PAA 
Fetal calf serum  Sigma  
 
6.1.6 Mass spectrometry material 
0.2 ml tubes, strips of 8 (low binding) Nunc 
0.5 ml tubes (low binding)  Eppendorf LoBind 
Acetonitrile  Sigma 
Formic acid  Sigma 
H2O HPLC grade  Merk 
Propionic acid  Merk 
TFA  Merk 
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6.2 Methods 
6.2.1 Cell biology methods 
6.2.1.1 Cultivation of mammalian cells 
Female Mouse Embryonic Fibroblasts cells (MEFs) were grown under standard conditions in 
Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% Fetal Bovine Serum 
(Sigma) and 1x penicillin/streptomycin (PAA). Human Hodgkin’s Lymphoma cell lines L-
1236, L-540, L-428, HDLM-2, and KM-H2  were obtained from the Deutsche Sammlung für 
Mikroorganismen und Zellkulturen (Braunschweig, Germany). HL cell lines and control 
Epstein-Barr virus-immortalised cell lines (LCL) were cultured in RPMI 1640/GlutaMAX 
(Gibco) supplemented with 10% Fetal Bovin Serum (Sigma), betamercaptoethanol, and 1x 
penicillin/streptomycin (PAA). Peripheral blood mononuclear cells (PBMC) from healthy 
donors and patients with HL were isolated as described with informed consent and approval 
by the ethics committee of the Medical Faculty of the Martin Luther University Halle-
Wittenberg.  
6.2.1.2 Transfection 
MEF cells were transfected with H2A.Bbd-GFP and GFP-H2A expression plasmids using 
FuGENE® HD transfection reagent (Roche) according to the manufacturer’s instructions. 
Stable cell lines were selected using G418 (PAA) at a concentration of 600 µg/ml. The GFP-
macroH2A expression plasmid was transfected using the TransIT LT1 reagent (Mirus) 
according to the manufacturer’s instructions. For live cell imaging MEF cells stably 
expressing GFP-H2A.Bbd were transfected with mRFP-PCNA using Amaxa nucleofection as 
previously described.  
6.2.1.3 FACS sorting and FACS analysis 
GFP single cell sorting was carried out using a MoFlo cell sorter (Beckman Coulter). Single 
cell clone suspensions of GFP-H2A.Bbd, GFP-macroH2A and GFP-H2A MEFs were 
analysed using FACS Canto. The GFP signal was detected in the FITC channel and the data 
analysis to quantify the GFP positive cells was performed using FlowJo software. 
6.2.1.4 Immunofluorescence 
Cells grown on glass coverslips were fixed in PBS/3.7% FA (Roth:7398.1) 10 minutes at 
room temperature. After fixation the cells were washed in PBS and the permealized in 3.3 
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mM sodium citrate and 0.1% TRITON X-100, for 5 min at room temperature. The cells were 
then washed 2 times with PBS and 2 times with washing solution I (PBS-Tween (0.1%) plus 
0.25% BSA). Blocking was performed with blocking solution I (5 ml washing solution I/2.5% 
BSA) for 30 min at room temperature. Primaries antibodies were diluted in the blocking 
solution I. Incubation with the primary antibody was performed overnight at 4°C. The day 
after the cells were washed with washing solution I and incubated with the seconday 
antibodies diluted in blocking solution II (blocking solution I plus 10% normal goat serum) 
for 1 hour at room temperature. Slides were mounted with Vectashield containing DAPI 
(Vectore Laboratories) and sealed with nail polish. Images were acquired using a Zeiss LSM 
510 META confocal microscope equipped with a 63x oil immersion objective NA=1.4 or a 
Leica TCS SP5 confocal microscope with a 63x glycerol immersion objective NA = 1.3. 
Digital image processing, light linear adjustment of brightness and contrast was done using 
ImageJ. 
The primary antibodies used were anti-H3K27me3 (kind gift of Gunnar Schotta) and anti-
GFP (mixture of mouse monoclonal antibodies from Roche). For detection the cells were 
stained with donkey anti-mouse Alexa 488 (Jackson Immuno Research); goat anti-rabbit Cy3 
(Millipore); TO-Pro-3 (Invitrogen). For live cell imaging MEF transfected cells were plated 
on a glass bottom p35 dish and grown under standard conditions. 3D stacks were acquired at 
20-min intervals overnight. Time lapse imaging was carried out on a UltraVIEW VoX 
spinning disc confocal system (PerkinElmer, UK) in a closed live cell microscopy chamber 
(ACU control, Olympus, Japan) heated to 37°C, with 5% CO2 and 60% air humidity control, 
mounted on a Nikon Ti microscope (Nikon, Japan), using a 60x/1.45 NA Planapochromat oil 
immersion objective lens. Images were obtained with a cooled 14-bit EMCCD camera 
(C9100-50, CamLink). Maximum intensity Z-projections were assembled into videos and 
annotated using ImageJ (http://rsb.info.nih.gov/ij/). For CPD analysis cells were grown on 
glass coverslips. Fixation of the cells was done with 3.7% formaldehyde for 10 min at room 
temperature followed by a combined permeabilization and DNA denaturation step with ice 
cold 0.7% Triton X-100/ 0.4 N HCL/ PBS for 10 min. For blocking step, the cells were 
incubated with 4% BSA for 30 min. Immunostaining for CPD was performed by incubating 
the cells with monoclonal anti-CPD (Kamiya Biomedical Company, Cat no: MC-062) at a 
dilution of 1:200 for 1 hour at room temperature. For detection, cells were incubated with 
polyclonal anti mouse IgG Cy3 (Jackson Laboratories, Cat no: 715-165-151) at a dilution of 
1:330 for 1 hour at room temperature. The DNA content was stained with 4',6-diamidino-2-
phenylindole (DAPI) and finally mounted in Mowiol 4-88 (Sigma-Aldrich Chemie).  
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6.2.1.5 In situ replication labeling  
To visualize newly synthesized DNA, cells grown on coverslips were pulse labeled with 
either 10 µM EdU (Fig. 4) or 100 µM 5-bromo-2′-deoxyuridine (BrdU, Sigma-Aldrich) (Fig. 
5) and either fixed immediately or chased for the indicated time in pre-warmed medium 
supplemented with 200 µM thymidine. Cells were fixed with 3.7 % formaldehyde for 10 
minutes and permeabilized with 0.5 % Triton X-100 for 20 minutes. BrdU detection was 
performed with rat-anti-BrdU (Gentaur, Cat no: OBT0030CX, dilution 1:100) in the presence 
of DNaseI as described (Casas-Delucchi et al.,2012). Click reaction was performed using the 
click-it kit (Invitrogen). Alexa Fluor 647 azide was added in a final concentration of 2 µM. 
The click reaction was performed for 30 minutes at room temperature. The cells were then 
stained with anti-GFP as described above. 
6.2.1.6 Microirradiation experiments 
Microirradiation experiments were carried out in Nikon Ti spinning disc microscope (see live 
cell imaging) with a 405 nm diode laser set to 100% transmission. Approximately 1 µm spots 
were selected inside the nucleus and microirradiated with 1 mJ. Pre and post bleach images 
were acquired as indicated. 
6.2.1.7 UV-C irradiation experiments 
For UV-C irradiation experiments, the cells were irradiated with a UV-C source containing 
5.8 W short wave lamps (Amersham Biosciences) at a wavelength of 254 nm. For damage 
induction the media was removed from the cells and were globally irradiated for 10 seconds 
with a final dose of 1 mJ/cm2. Unirradiated cells were used as control. 
6.2.1.8 CPD Quantification 
The levels of DNA damage were calculated from confocal 3D images of CPD stainings and 
DNA counterstained with DAPI using the image analysis platform Priithon 
(http://code.google.com/p/ priithon/). The DAPI images were used to create 3D nuclear masks 
by applying a median filter (sigma = 500 nm) and segmenting the filtered images using 
automatic thresholding. The integrated CPD signal within the nuclear mask was divided by 
the mask volume to obtain the mean CPD intensity in each nucleus. 
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6.2.2 Molecular biology methods 
6.2.2.1 Quantitative reverse transcription-polymerase chain reaction 
RNA from HL cell lines and PBMC was isolated using Trizol reagent (Invitrogen, Karlsruhe, 
Germany) following the manufacturer’s protocol. After reverse transcription of 2 µg of RNA, 
quantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed 
essentially as described (Neumann et al., 2010). The following primer combinations have 
been used: actin beta (ACTB): 5’-ggc atc gtg atg gac tcc g-3’ and 5’-gct gga agg tgg aca gcg 
a-3’; H2A.Bbd: 5’-tcg ttt tca gtg agc cag gt-3’ and 5’-cag aat taa tga agg ccc aag-3’. 
Quantification of gene expression was performed using the 2-ΔΔCt method [H] and for 
comparative analysis, the median Dct value from PBMC (21 independent donors) was set as 
one. 
 
6.2.3 Biochemical methods 
6.2.3.1 Chromatin purification 
Adherently growing mouse embryonic fibroblasts (MEFs) were detached by trypsinisation 
followed by centifugation at 200 g. Cells were washed twice with PBS and nuclei were 
isolated by the addition of ice-cold 0.3% Triton-X dissolved in PBS. After a 10 min 
incubation step at 4°C nuclei were pelleted for 10 min at 1000 xg, washed once with PBS and 
resuspended in EX-100 (100 mM Hepes pH 7.6); 100 mM NaCl; 1.5 mM MgCl2; 0.5 mM 
EGTA; 10% v/v Glycerol) freshly supplemented with proteinase inhibitors. Chromatin was 
solubilized by 20 min Microccocal Nuclease (MNase) digestion at 26°C in the presence of 
2 mM CaCl2. The reaction was stopped by adding 1/50 th volume of 0.5 M EGTA. All further 
steps were carried out at 4°C. The first supernatant (S1) was recovered after centrifugation at 
1000xg and the pellet was resuspended in resuspension buffer (1x PBS; 150 mM NaCl; 2 mM 
EDTA; 0.1% Triton) and over-head rotated over night (o/n) to further extract solubilized 
chromatin fragments. A second supernatant (S2) was recovered by a 30 min centrifugation, 
pooled with the first supernatant to yield the purified chromatin. A chromatin aliquot was 
used to check the MNase digestion by isolating the DNA fragments obtained.  
6.2.3.2 GFP affinity purification 
MNase digested chromatin was precleared with 20 µl of slurry agarose beads for 1 h at 4°C. 
The supernatant was collected after 2 minutes of centrigugation at 2000xg, 4°C. 20 µl of 
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slurry GFP binders (Chromotek) were equilibrated 3 times with EX-100 (100 mM Hepes pH 
7.6; 100 mM NaCl; 1.5 mM MgCl2; 0.5 mM EGTA; 10% v/v Glycerol) and then added to the 
supernatant. Immunoaffinity purification was performed for 2 h at 4oC. The beads were 
washed 3 times with Resuspension Buffer (1x PBS; 150 mM NaCl; 2 mM EDTA; 0.1% 
Triton) plus proteinase inhibitors and centrifuged at 4oC at 2000xg. 15 µl of 2X Laemmli 
buffer were added to the beads and boiled 15 minutes at 95°C.. Samples were run on a 15% 
SDS gel for 2 cm and stainded with Coomassie Brilliant Blue G250 for 20 minutes. After 
destaining with 10% acetic acid every lane was cut into 8 slices and every slice was collected 
into a tube. 
6.2.3.3 Trypsin in-gel digestion and mass spectrometry 
Gel pieces were washed once with milliQ water and two times with NH4HCO3 20 mM. 
Destain of the gel pieces was preformed in 50% ACN 50% NH4HCO3 at 37°C for 1 hour. 
Samples were washed two times with 20 mM NH4HCO3 and dehydrated with ACN ultrapure. 
Reduction was performed in 10 mM DTT diluted in 20 mM NH4HCO3, 1 hour at RT. 
Alkylation of the gel pieces was done in 50 mM IAA diluted in NH4HCO3, 30 minutes at RT 
in the dark. Before tryptic digestion the samples were washed once with 20 mM NH4HCO3 
and dehydrated with 100% ACN. 30 to 50 µl of 25 ng/µl Trypsin were added to the gel pieces 
in ice till the gel pieces hydrated completely. Non absorbed trypsin was removed and 50 µl of 
20 mM NH4HCO3  were added. The samples were incubated overnight at 37°C. The day after 
the peptides were collected and placed in a fresh tube and acid extraction was performed as 
follow. The gel pieces were incubated twice in 50% ACN- 0.25% TFA, 10 minutes at room 
temperature followed by two times 100% ACN, 10 minutes at room temperature. The 
peptides were collected and pooled together with the first supernatant. The samples were 
dried and then resuspended in 15 µl 0.1% FA. 50% of the sample was injected in an Ultimate 
3000 HPLC system (LC Packings Dionex). Samples were desalted on-line by a C18 micro 
column (300 mm i.d. 5 mm, packed with C18 PepMapTM, 5 mm, 100 Å by LC Packings), 
and peptides were separated with a gradient from 5% to 60% acetonitrile in 0.1% formic acid 
over 40 min at 300 nl/min on a C18 analytical column (75 mm i.d.x10 cm, packed with C18 
PepMapTM, 3 mm, 100 Å by LC Packings). The effluent from the HPLC was directly 
electrosprayed into the LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific). The MS 
instrument was operated in the data-dependent mode to automatically switch between full 
scan MS and MS/MS acquisition. Survey full scan MS spectra (m/z 580-830) were acquired 
in the Orbitrap with resolution R= 60 000 at m/z 400. The six most intense peptide ions with 
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charge states between two and five were sequentially isolated (window = 350-2000 m/z) to a 
target value of 10000 and fragmented in the linear ion trap by collision-induced dissociation 
(CID). Fragment ion spectra were recorded in the linear trap of the instrument. For all 
measurements with the Orbitrap detector, three lock-mass ions from ambient air 
(m/z=371.10123, 445.12002, 519.13882) were used for internal calibration as described. 
Typical mass spectrometric conditions were: spray voltage, 1.4 kV; no sheath and auxiliary 
gas flow; heated capillary temperature, 200°C; normalized collision energy, 35% for CID in 
linear ion trap. The ion selection threshold was 10000 counts for MS2. An activation q=0.25 
and activation time of 30 ms were used. 
6.2.3.4 Mass spectrometry data analysis 
For protein identification the raw data were analysed with the Andromeda algorithm of the 
MaxQuant protein analysis package (version 1.2.2.5) against the IPI mouse v.3.68.Fasta 
including reverse sequences and contaminants. The Trypsin/P enzyme was selected, allowing 
for maximally 2 missed cleavages. Carbamidomethylation of C was set as fixed modification 
whereas methionine oxidation and protein N-acetylation were included as variable 
modifications. The mass tolerance of the initial search was 20 ppm; after recalibration, a 
6 ppm mass error was applied for the main search. Fragment ions were searched with a mass 
offset of 0.5 Da using the 6 most intense signals per 100 Da. Searching for secondary peptide 
hits within already assigned MS/MS spectra was enabled. The search results were filtered 
with a peptide and protein false discovery rate of 0.01 with a minimum peptide length of 6 
amino acids. Protein identifications with at at least one unique or razor peptide were accepted. 
For the quantification the Intensity Based Absolute Quantification (iBAQ) values were 
calculated from peptide intensities and the protein sequence information (Schwanhäusser et 
al., 2011) of unmodified, M/oxidated and acetylated peptide species with a minimum of 2 
peptides per protein. 
6.2.3.5 Statistical data analysis 
Statistical analysis of protein enrichment was performed from the three affinity purification-
MS replicates of the three GFP-H2A variants. First, all replicates were normalized using the 
median of abundant histone H4 peptides, including only peptides without modifications, less 
than 2 missed cleavages and excluding tryptic cleavage after Pro, as normalization factor. The 
control samples (NoGFP) data were not normalized, since detected H4 levels were to low. 
Secondly, normalized iBAQ values were log2 transformed and missing values were imputed 
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from a gaussian distribution which was shifted by a difference of about 2.5 and had a width of 
0.3 using the Perseus software tool (Cox and Mann, 2012) The average difference of the GFP-
H2A variants over the control samples (NoGFP) was calculated and only proteins having a 
difference of more than 3.5 and quantiative information in at least two experiments were kept. 
To determine enrichment factors and p-values for enrichment, ANOVA was perfromed in 
DanteR and resulting p-values were subsequently corrected for multiple hypothesis testing 
using the Benjamini-Hochberg method in DanteR (Benjamini and Hochberg, 2008). Data 
were plotted with Perseus software. The Gene Ontology was performed using the Database 
for Annotation, Visualization and Integrated Discovery (DAVID) version 6.7. (Huang et al., 
2009a; 2009b). Functional Annotation Chart were created using default settings. 
6.2.3.6 Histone preparation for mass spectrometry 
For histone modifications analysis, histones were separated by 15% SDS–PAGE and stained 
with Coomassie blue for 20 minutes at RT. After destaining with 10% acetic acid, the histone 
bands for H3 and H4 were excised from the gel and placed in a 0.5ml low binding tube 
(Eppendorf LoBind). The pieces were washed once with 200 µl milliQ water (Merk) and once 
with 200 µl 10 mM NH4HCO3 for 5 min. at 37°C. The destain was obtained incubating the gel 
pieces in 200 µl of 50%ACN/50 mM NH4HCO3 for 30-60 min. at 37°C. In case of partial 
destaining, the step was repeated again once. At this point the protocol can be stopped and the 
gel pieces can be stored in milliQ water at 4°C overnight. Histone lysine acylation was 
perfomed adding 1 µl of propionic anhydride in the sample tubed followed by 10 µl of 0.1 M 
NH4HCO3. Due to the production of CO2 the tubes were opened and closed several time after 
the reaction started. The reaction was performed adding 1 M NH4HCO3 to cover the gel 
pieces. The reaction was perfomed at 37°C for 30-60 min. To prevent the aspecific acrylation 
the pH of the reaction was monitored and kept between 7-8. After removing the supernatant 
the gel pieces were washed three times with 0.1M NH4HCO3 for 10 min. at room temperature 
followed by one time with milliQ water and one time with 50% ACN for 15 min. at room 
temperature. To avoid aspecific N-terminal acylation the washing steps were never shorter 
than the time requested. The dehydration of the gel pieces is perfomed by washing the gel 
pieces two times with 100% ACN on ice. Trypsin digestion was perfomed using 0.2 ng of 
trypsin. The  trypsin absorbtion in the gel pieces was obtained using 10 µl of 50 mM 
NH4HCO3 in ice for 5 min. After trypsin absorbion the gel pieces were incubated in 30 µl 
50 mM NH4HCO3 overnight at 37°C. The day after the peptides released in the supernatant 
were collected in a fresh tubes and 1/3 of the sample was used for mass spectrometry 
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measurament. The method applied for the LC-MS/MS is the same as described in the 
proteomic analysis of the purified chromatin. 
6.2.3.7 Histone modifications data analysis 
To determine all modifications occurring on histones the spectra were processed and analyzed 
with the XCalibur Qual Browser software (Thermo Fisher Scientific). Doubly and triply 
charged peptides were quantified by using the masses of the corresponding extracted ion 
chromatograms (XICs). The sum of the area from all peaks derived from a single peptide was 
defined as 100% and the relative percentage for a single modification was calculated 
accordingly. All the calculations were performed manually in Excel. 
6.2.3.8 Nuclear extract for western blot analysis 
GFP-histone variants transfected MEFs and Hodgkin’s Lymphoma cell lines were incubated 
with 0.1% Triton in PBS supplemented with proteinase inhibitor for 10 minutes at 4°C. After 
centrifugation at 3000 rpm the nuclei pellet was resuspended in 1X PBS supplemented with 
proteinase inhibitors and the DNA was digested with Benzonase (VWR) for 15 minutes at 
37°C. 2X Laemmli buffer was added to the nuclei suspension and boiled 15 minutes at 95°C 
6.2.3.9 Western Blot antibodies 
anti-GFP antibodies: a mixture of two mouse anti-GFP monoclonal antibodies (Roche) was 
used at a dilution of 1:1000, the H3 antibody (Abcam ab1719) was used at a concentration of 
1:5000, H2A.Bbd 1:1000 (Millipore polyclonal). HRP-coupled secondary antibodies were 
used at a concentration of 1:5000 and detection was performed using ECL 
chemiluminescence. 
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7 Abbreviations  
3C  chromosome conformation capture 
4-HB  4-helix bundle 
BMI1 Polycomb Complex Protein 1 
Bp  basepair 
CAF1  Chromatin Assembly Factor 1 
CBX8 Chromobox protein homolog 8 
CENP-A  Centromeric Protein A 
ChIP  chromatin immunoprecipitation 
Cid  Centromeric Identifier 
CPD cyclobutane pyrimidine dimer 
CTA  Cancer Testis Antigens 
DAPI 4',6-diamidino-2-phenylindole 
DIPG diffuse intrinsic pontine glioma 
DNA deoxyribonucleic acid 
DSB  double strand breaks 
EBV Epstein-barr virus 
EdU 5-ethynyl-2′-deoxyuridine 
EM  electron microscopy 
EMANIC  electron microscopy-assisted nucleosome capture 
EMSA  electrophoretic mobility shift assay 
FACS  fluorescence-activated cell sorting 
FACT  facilitated chromatin transcription complex 
FISH  fluorescence in situ hybridization 
FRAP  fluorescent recovery after photobleaching 
GBM glioblastoma multiforme 
GFP  Green Fluorescent Protein 
GO  Gene Ontology 
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h hour 
H2A.Bbd  H2A Barr body deficient 
H3/H4/H2A/H2B/H1   histones 
HCC hepatocellular carcinoma 
HDAC1/2  histone deacetylase 1/2 
HL  Hodgkin’s Lymphoma 
HP1  heterochromatin protein 1 
HZH2  Enhancer of zeste homolog 2 
iBAQ  intensity based absolute quantification 
K  lysine 
kDa  kilodalton 
L1  loop1 
L2  loop2 
LAD  lamina-associated-domains 
LCL lymphoblastoid cell lines 
Mb  megabase 
MCM  mini chromosome maintenance 
me  methylation 
MEFs  Mouse Embryonic Fibroblasts 
Mg  magnesium 
mM  millimolar 
mRNA  messenger RNA 
NaCl  Sodium Chloride 
NAP1  Nucleosome assembly protein 1 
NCP  nucleosome core particle 
NHR  non-histone region 
nm  nanometer 
PARP1  poly-ADP polymerase 1 
PcG  Polycomb group 
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PCNA  proliferating cell nuclear antigens 
PRC1/2  Polycomb repressive complex 1/2 
qPCR quantitative polymerase chain reaction 
S-phase Synthesis phase 
SPOP  speckle-type POZ domain protein 
SUV39 suppressor of variegation 3-9  
TH2B testis specific H2B 
TSS  transcription start site 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  74 
8 Acknowledgement 
First of all I would like to thank Prof. Dr. Axel Imhof for giving me the opportunity to work 
in his group and for his scientific supervision and support.  
 
I thank Prof. Dr. Peter Becker for providing and excellent and motivating scientific 
environment at the Adolf Butenandt Institute. 
 
A special thank goes to all the member of my group and in particular to Dr. Andreas Thomae 
(Postdoc!) for being always there in case of a ‘scientific emergency’ and for being always 
willing to share his great knowledge with me.  
 
I also thank Irene Vetter, for her great technical support and for her tutorials about the 
Bavarian culture. 
 
I would like to truly thank Teresa, Simo and Miri, for sharing the last five years of PhD 
together in ‘good and bad times’, but most of all for their friendship and constant help in 
understanding the German world. 
 
Ringrazio Alessandra e Dario, per aver portato un po’ di casa ogni giorno in laboratorio tra 
risate, battute e caffe,’ anche nei giorni piu’ freddi e cupi. 
 
Ringrazio i miei amici lontani, in particolare Antonia ed Elisabetta, per essermi rimaste vicine 
e per aver continuato a condividere la propria vita con me quotidianamente, magari durante 
una improbabile cena virtuale.  
 
Infine, un ringraziamento speciale va ad Enza, Sandro e Serena, per avermi incoraggiato a 
seguire i miei sogni e le mie aspirazioni nonostante queste mi abbiano portato lontano da casa. 
Grazie davvero! 
 
  
  75 
9 Curriculum vitae 
Personal information 
Name    Viola Sansoni 
Date of birth  28/02/1983 
City of birth  Priverno (Italy) 
Nationality  Italian 
 
Education 
04/2009- 07/2014 PhD student  
   Adolf Butenandt Institute, LMU, Munich, Germany  
   Prof. Dr. Axel Imhof 
09/2006- 10/2008 Master Degree in Molecular Biology 
   University La Sapienza, Rome, Italy 
09/2001- 07/2006 Bachelor Degree in Biology 
   University La Sapienza, Rome, Italy 
09/1996- 07/2001 Liceo Classico ‘Dante Alighieri’, Anagni, Italy 
 
Publications 
Viola Sansoni, Corella S. Casas-Delucchi, Malini Rajan, Andreas Schmidt,Clemens Boenisch, 
Andreas W. Thomae, Martin S. Staege, Sandra B. Hake, M.Cristina Cardoso and Axel Imhof 
The histone variant H2A.Bbd is enriched at sites of DNA synthesis, Nucleic Acid Research, 
2014 
Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Cordone S, Taurino M, Serino M, 
Marano G, Federici M, Pricci F, Pugliese G., Arteriosclerosis Thrombosis Vascular Biology. 
Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via 
receptor-mediated mechanisms, Atherosclerosis Thrombosis Vascular Biology, 2009 
Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Mazzitelli G, Cordone S, Pesce C, 
Pugliese F, Pricci F, Pugliese G. Advanced lipoxidation enr-products mediate lipid- induced 
glomerular injury: role of receptor-mediated mechanisms, Journal of Pathology, 2009 
  76 
10 Appendix 
10.1 Table I. Gene Ontology analysis of proteins enriched in the GFP-H2A.Bbd 
over the GFP-macroH2A.1.2 containing chromatin 
Term Count % PValue Bonferroni Benjamini FDR 
RNA processing 100 17.5 3.32E-59 3.71E-56 3.71E-56 5.33E-56 
translation 75 13.2 1.35E-44 1.51E-41 7.55E-42 2.17E-41 
mRNA processing 65 11.4 5.53E-40 6.17E-37 2.06E-37 8.86E-37 
ribosome biogenesis 45 7.9 1.22E-37 1.36E-34 3.40E-35 1.95E-34 
RNA splicing 56 9.8 3.24E-37 3.62E-34 7.23E-35 5.19E-34 
mRNA metabolic process 66 11.6 5.59E-37 6.24E-34 1.04E-34 8.96E-34 
ribonucleoprotein complex 
biogenesis 47 8.2 1.10E-35 1.23E-32 1.76E-33 1.76E-32 
rRNA processing 29 5.1 9.06E-24 1.01E-20 1.26E-21 1.45E-20 
rRNA metabolic process 29 5.1 1.40E-23 1.57E-20 1.74E-21 2.25E-20 
chromatin organization 47 8.2 5.21E-19 5.82E-16 5.82E-17 8.35E-16 
chromosome organization 53 9.3 6.67E-19 7.44E-16 6.77E-17 1.07E-15 
ncRNA processing 31 5.4 7.42E-16 8.67E-13 7.23E-14 1.24E-12 
ncRNA metabolic process 31 5.4 6.50E-13 7.25E-10 5.58E-11 1.04E-09 
DNA replication 27 4.7 8.31E-13 9.28E-10 6.63E-11 1.33E-09 
chromatin modification 33 5.8 1.38E-12 1.54E-09 1.03E-10 2.22E-09 
DNA metabolic process 44 7.7 3.61E-12 4.03E-09 2.52E-10 5.78E-09 
covalent chromatin modification 20 3.5 7.62E-11 8.50E-08 5.00E-09 1.22E-07 
histone modification 19 3.3 2.95E-10 3.30E-07 1.83E-08 4.73E-07 
chromatin assembly or 
disassembly 20 3.5 7.51E-10 8.38E-07 4.41E-08 1.20E-06 
cellular macromolecular complex 
assembly 25 4.4 5.55E-08 6.20E-05 3.10E-06 8.89E-05 
histone acetylation 11 1.9 6.14E-08 6.86E-05 3.27E-06 9.84E-05 
protein amino acid acetylation 11 1.9 8.28E-08 9.24E-05 4.20E-06 1.33E-04 
cellular macromolecular complex 
subunit organization 25 4.4 5.41E-07 6.04E-04 2.63E-05 8.67E-04 
transcription 91 16.0 6.46E-07 7.21E-04 3.00E-05 0.001 
protein amino acid acylation 11 1.9 1.53E-06 0.002 6.84E-05 0.002 
histone H4 acetylation 8 1.4 1.95E-06 0.002 8.38E-05 0.003 
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10.2 Table II. Gene Ontology analysis of proteins enriched in the GFP-H2A.Bbd 
over the GFP-H2A containing chromatin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Term Count % PValue Bonferroni Benjamini FDR 
RNA processing 90 18.6 1.61E-55 1.66E-52 1.66E-52 2.56E-52 
translation 73 15.1 7.94E-48 8.15E-45 4.07E-45 1.26E-44 
mRNA processing 60 12.4 5.30E-39 5.43E-36 1.81E-36 8.40E-36 
RNA splicing 53 11.0 1.18E-37 1.21E-34 3.02E-35 1.87E-34 
mRNA metabolic process 61 12.6 2.38E-36 2.44E-33 4.88E-34 3.77E-33 
ribosome biogenesis 40 8.3 6.15E-34 6.31E-31 1.05E-31 9.75E-31 
ribonucleoprotein complex 
biogenesis 41 8.5 2.40E-31 2.46E-28 3.52E-29 3.80E-28 
rRNA processing 24 5.0 3.70E-19 3.80E-16 4.75E-17 5.87E-16 
rRNA metabolic process 24 5.0 5.21E-19 5.35E-16 5.94E-17 8.26E-16 
ncRNA processing 26 5.4 3.25E-13 3.34E-10 3.34E-11 5.16E-10 
ncRNA metabolic process 26 5.4 8.46E-11 8.68E-08 7.89E-09 1.34E-07 
chromatin organization 31 6.4 7.43E-10 7.62E-07 6.35E-08 1.18E-06 
chromosome organization 34 7.0 5.25E-09 5.39E-06 4.14E-07 8.32E-06 
DNA replication 20 4.1 1.39E-08 1.42E-05 1.02E-06 2.20E-05 
DNA metabolic process 31 6.4 5.34E-07 5.48E-04 3.66E-05 8.47E-04 
chromatin modification 22 4.5 8.78E-07 9.01E-04 5.63E-05 0.001 
cellular macromolecular complex 
assembly 21 4.3 9.26E-07 9.50E-04 5.59E-05 0.001 
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10.3 Table III. List of proteins enriched in the GFP-H2A.Bbd compared to the 
GFP-macroH2A.1.2 and GFP-H2A containing chromatin. 
Gene name IPI number Uniprot bbd vs macro pvalue 
log2  
bbd vs 
H2A 
pvalue 
Fin13;Ppm1g IPI00117072 Q61074 17.53 0.00048 18.90 0.00045 
Rpl19 IPI00122426 P84099 16.95 0.03664 4.65 0.62298 
Rpl36 IPI00869475 Q5M9L1 16.64 0.00319 6.79 0.07355 
Rpl35 IPI00263879 Q6ZWV7 16.42 0.04882 3.72 0.73830 
Rplp2 IPI00139795 P99027 15.51 0.06783 5.54 0.59351 
Csda;Msy4 IPI00274739 Q9JKB3-2 15.10 0.00668 3.72 0.39704 
Rps24 IPI00465568 P62849-1 14.86 0.00790 5.98 0.17831 
Rpl22 IPI00222546 P67984 14.78 0.00278 4.27 0.17057 
Rpl34 IPI00466153 Q9D1R9 14.76 0.00429 3.36 0.36442 
Rplp1 IPI00113377 P47955 14.73 0.07042 4.92 0.62751 
Rps19 IPI00875584 Q5M9P3 13.22 0.02496 4.31 0.47935 
Rpl24 IPI00323806 Q3UW40 13.20 0.07783 3.98 0.69359 
Ddx49 IPI00354271 Q4FZF3 13.02 0.00013 13.34 0.00014 
Purb IPI00128867 O35295 12.69 0.00790 5.68 0.13861 
Top1 IPI00109764 Q04750 12.63 0.01648 1.80 0.77044 
1810009A15Rik IPI00112004 Q9CSS6 12.54 0.00649 4.01 0.24924 
Npm1 IPI00127415 Q61937 12.44 0.12993 3.14 0.80998 
Brix;Brix1 IPI00130436 Q9DCA5 12.40 0.00964 12.51 0.01255 
Ebna1bp2 IPI00111829 Q9D903 12.33 0.04950 11.95 0.07369 
Phf14 IPI00415328 Q9D4H9-2 12.23 0.00631 5.06 0.12589 
Caper IPI00223371 Q8VH51-2 12.22 0.02665 2.65 0.68362 
Nol5 IPI00463468 Q6DFW4 12.11 0.14087 2.63 0.84404 
Cenpa IPI00128526 O35216 12.05 0.00011 12.31 0.00009 
Kiaa1820 IPI00890011 Q61818-2 11.98 0.00017 6.32 0.00304 
Eif6 IPI00857575 A6PWZ2 11.94 0.01036 11.56 0.01480 
Unnamed protein IPI00626366 
 
11.89 0.04653 10.93 0.08102 
Ccdc86 IPI00402914 Q9JJ89 11.84 0.00362 2.28 0.43004 
Gnl3 IPI00222461 Q8CI11-1 11.80 2.71E-09 5.64 1.13E-07 
Top2b IPI00135443 Q64511 11.77 0.00470 3.92 0.18894 
Nol1;Nop2 IPI00311453 Q922K7 11.63 0.00668 1.66 0.67876 
Rsl1d1 IPI00226149 Q3TAJ5 11.56 0.14181 3.07 0.80492 
Llrep3;Rps2 IPI00880400 P25444 11.48 0.22453 3.82 0.79884 
Mbd2 IPI00131088 Q9Z2E1-1 11.14 0.02496 5.89 0.21179 
Llph IPI00112043 Q9D945-1 11.12 0.02191 8.24 0.07369 
Ddx50 IPI00117771 Q99MJ9 11.11 0.01057 2.56 0.52428 
C7orf50 homolog IPI00110456 Q9CXL3 11.07 0.01591 1.70 0.74887 
Igf2bp3 IPI00331315 Q9CPN8 10.91 0.09223 9.87 0.17057 
Polr2g IPI00263106 P62488 10.89 0.00019 11.48 0.00019 
Atrx;Hp1bp2 IPI00322707 Q61687 10.84 0.00429 2.27 0.41933 
Ssr1 IPI00110852 Q52PE3 10.80 0.06411 7.73 0.21252 
Polr2h IPI00124284 Q923G2 10.62 0.08410 9.20 0.17594 
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Rpl14 IPI00473728 Q9CWK0 10.61 0.13268 3.85 0.69893 
Nhp2 IPI00133550 Q9CRB2 10.58 0.23076 3.23 0.82172 
P198 IPI00223217 P19253 10.57 0.05072 3.31 0.61120 
C3orf26 homolog IPI00113109 Q9CZT6 10.53 0.06089 7.55 0.20667 
Polr2d IPI00268215 Q9D7M8 10.38 0.00261 8.82 0.00585 
Dnaj2 IPI00132208 P63037 10.29 0.00012 10.26 0.00013 
Polr2c IPI00875500 Q99M46 10.28 0.08328 2.59 0.75624 
Rpl36a IPI00225066 P83882 10.23 0.09990 2.13 0.82373 
Ddx18 IPI00459381 Q8K363 10.22 0.00221 3.25 0.09561 
Igf2bp1 IPI00131056 O88477 10.21 0.02968 8.81 0.06492 
Zan75 IPI00314507 O88291-1 10.20 0.07873 7.83 0.21252 
Ssrp1 IPI00407571 Q08943-2 10.13 0.00919 4.31 0.17831 
Zfr IPI00131810 O88532 10.13 0.03028 5.64 0.21252 
Mrt4 IPI00132578 Q9D0I8 10.05 0.18469 6.79 0.47935 
Ddx6 IPI00109932 P54823 10.00 0.00278 8.38 0.00660 
Bxdc1 IPI00121159 Q9JJ80 9.99 0.09235 7.88 0.23169 
MNCb-2643 IPI00318725 Q9CYH6 9.98 0.03183 8.78 0.06558 
Ssr3 IPI00120826 Q9DCF9-1 9.98 0.00820 9.72 0.01255 
D19Bwg1357e IPI00222675 Q8BKS9 9.96 0.01036 4.45 0.17594 
Snrnp70 IPI00625105 Q62376-1 9.96 0.02496 9.13 0.04460 
Pura IPI00118447 P42669 9.95 0.09372 4.17 0.58358 
A301 IPI00123005 Q810D6 9.86 0.00002 7.70 0.00007 
Mta1l1 IPI00128230 Q9R190 9.86 0.01288 2.87 0.43117 
Fact140 IPI00120344 Q920B9 9.86 0.01665 5.35 0.14979 
D13Wsu177e IPI00458704 Q9CPT5 9.85 0.06089 6.43 0.24924 
Ssr4 IPI00953773 Q9D6F7 9.83 0.09842 10.00 0.13273 
Rpl10a IPI00849927 Q3U561 9.82 0.21551 5.03 0.64107 
Ddx47 IPI00187240 Q9CWX9 9.81 0.13911 6.21 0.44546 
Npm3 IPI00131725 Q9CPP0 9.81 0.03466 12.23 0.02281 
Crfg;Gtpbp4 IPI00117642 Q99ME9 9.75 0.00877 9.79 0.01209 
Mnar;Pelp1 IPI00321597 Q9DBD5 9.70 0.02431 0.97 0.86489 
Meaf6 IPI00110388 Q2VPQ9-2 9.69 0.02298 -0.52 0.93456 
Mta1 IPI00853911 Q8K4B0 9.67 0.00746 3.20 0.25882 
Spbp IPI00407458 Q9EPQ8-1 9.65 0.00558 4.81 0.06831 
Exosc6;Mtr3 IPI00466593 Q8BTW3 9.61 0.00790 8.92 0.01359 
Rpl8 IPI00137787 P62918 9.60 0.16309 1.86 0.86613 
Nhp2l1;Ssfa1 IPI00621272 Q9D0T1 9.59 0.19692 2.86 0.81243 
Rpl35a IPI00115902 O55142 9.58 0.15344 2.51 0.81407 
H1fx IPI00118590 Q80ZM5 9.56 0.04263 2.11 0.73542 
Srpk1 IPI00387234 O70551 9.55 0.00406 8.32 0.00879 
Rpl22l1 IPI00110724 Q9D7S7-1 9.54 0.01288 10.96 0.01160 
Ddx1 IPI00127172 Q91VR5 9.52 0.03119 9.75 0.03934 
Rfc4 IPI00653266 Q3UI84 9.51 0.07626 8.25 0.15511 
Ck2n;Csnk2b IPI00126762 P67871 9.43 0.10561 2.84 0.73840 
Glyr1;Np60 IPI00817029 Q922P9 9.43 0.00548 -0.64 0.85691 
Pabp1 IPI00124287 P29341 9.39 0.03061 2.63 0.59164 
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Rpl5 IPI00308706 P47962 9.35 0.39845 5.48 0.73740 
Polr2b;rpB2 IPI00320034 Q8CFI7 9.35 0.07344 5.37 0.35136 
Gclm;Glclr IPI00114329 O09172 9.33 0.01036 8.89 0.01578 
Hmg20a;Ibraf IPI00120110 Q9DC33-1 9.29 0.00048 8.43 0.00095 
Abcf2 IPI00116825 Q99LE6 9.22 0.00744 9.43 0.00948 
Kiaa0461 IPI00227539 Q8BZH4 9.21 0.00261 1.98 0.29768 
Nip7 IPI00133555 Q9CXK8 9.20 0.24776 2.77 0.82784 
Dpy30 IPI00117168 Q99LT0 9.19 0.03263 8.29 0.06486 
Las1l IPI00462502 A2BE28 9.16 0.02365 8.47 0.03974 
Yeats4 IPI00132946 Q9CR11 9.16 0.00820 9.87 0.00948 
Arf1 IPI00221613 P84078 9.15 0.19811 4.40 0.65766 
Rpl18a IPI00162790 P62717 9.13 0.15286 3.85 0.66583 
Csnk2a2 IPI00118795 O54833 9.12 0.04619 7.77 0.10184 
2700060E02Rik IPI00132456 Q9CQE8 9.11 0.11903 5.52 0.43494 
Nhn1;Zc3h18 IPI00673693 Q0P678-1 9.08 0.00011 3.74 0.00409 
Farp1 IPI00757373 C4IXU2 9.06 0.00099 9.23 0.00107 
mCG_1675;Sfrs6 IPI00310880 Q3TWW8 9.06 0.09853 2.30 0.77513 
Znhit1 IPI00857945 Q8R331 9.05 0.00048 7.74 0.00107 
Pcna IPI00113870 P17918 9.03 0.00416 9.26 0.00555 
Krip1;Trim28 IPI00312128 Q62318-1 8.96 0.01128 0.23 0.96168 
Exosc4;Rrp41 IPI00310857 Q921I9 8.95 0.00559 7.67 0.01176 
Rpl32 IPI00230623 P62911 8.94 0.18326 4.34 0.63200 
Bcas2 IPI00316184 Q9D287 8.90 0.00231 8.06 0.00409 
Sec61b IPI00755226 Q9CQS8 8.83 0.07926 9.37 0.09263 
Csl4;Exosc1 IPI00118360 Q9DAA6-1 8.81 0.02421 8.98 0.02976 
Luc7l IPI00410804 Q9CYI4-1 8.78 0.22783 8.32 0.33777 
Fusip1 IPI00314984 Q9R0U0-1 8.76 0.20605 0.19 0.98192 
Igf2bp2 IPI00761863 Q5SF07-1 8.75 0.00057 8.32 0.00095 
Ing4 IPI00515302 Q8C0D7-5 8.75 0.00295 2.17 0.25379 
Adnp IPI00672180 Q9Z103 8.74 0.07049 5.72 0.26984 
Mbd3 IPI00131067 Q9Z2D8-1 8.68 0.26312 3.45 0.77037 
Arf4;mCG_5889 IPI00876029 P61750 8.65 0.00261 7.31 0.00585 
Crop;Luc7l3 IPI00122418 Q5SUF2-2 8.64 0.00668 8.72 0.00888 
D3Wsu161e;Larp7 IPI00340860 Q05CL8-1 8.60 0.05838 7.04 0.14243 
Hrb2;Krr1 IPI00223570 Q8BGA5 8.59 0.00695 9.09 0.00866 
Luc7l2 IPI00380309 Q7TNC4-1 8.58 0.01370 9.26 0.01373 
C2f;Emg1 IPI00127554 O35130 8.56 0.03154 7.54 0.06506 
0610010K14Rik IPI00265101 Q9DCT6-1 8.55 0.16309 2.83 0.75624 
Ehmt1 IPI00555042 A2AIS3 8.52 0.01629 -0.99 0.82194 
Rpl13 IPI00224505 P47963 8.52 0.07882 3.79 0.51330 
Rpl15 IPI00273803 Q9CZM2 8.50 0.06147 3.41 0.51494 
Nol9 IPI00625464 Q3TZX8-1 8.49 0.00012 1.42 0.08777 
Exosc2;Rrp4 IPI00121437 Q8VBV3 8.48 0.07873 6.51 0.21252 
Surf6 IPI00137612 P70279 8.46 0.04941 7.83 0.08481 
Imp3 IPI00122383 Q921Y2 8.44 0.10808 2.17 0.78077 
Slc25a11 IPI00230754 Q9CR62 8.41 0.00254 8.25 0.00325 
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Prpf6 IPI00130409 Q91YR7-1 8.40 0.00208 2.74 0.08371 
Rpl31 IPI00123007 P62900 8.38 0.16728 4.20 0.60516 
Hnrpq IPI00406117 Q7TMK9-1 8.37 0.11770 3.98 0.56208 
Tcfl1 IPI00126141 Q62481 8.37 0.01201 7.99 0.01847 
Hnrnpul2 IPI00222208 Q00PI9 8.35 0.10783 3.03 0.67183 
Pmx;Pmx1 IPI00230653 P63013-2 8.31 0.06938 8.05 0.10301 
Actr6 IPI00110922 Q9D864 8.28 0.00161 8.61 0.00157 
Tcfubf IPI00114869 P25976-1 8.26 0.02431 0.81 0.86613 
Rbms2 IPI00121520 Q8VC70 8.19 0.00778 5.61 0.03681 
Hp1bp3 IPI00342766 Q3TEA8-1 8.18 0.08398 1.71 0.81243 
Gar1;Nola1 IPI00110931 Q9CY66-1 8.18 0.16350 3.52 0.66764 
Prpf4 IPI00458908 Q9DAW6 8.15 0.10051 6.08 0.27507 
C1qbp IPI00132799 Q8R5L1 8.14 0.19534 8.33 0.25704 
Rbm25 IPI00421119 B2RY56-1 8.11 0.01629 8.95 0.01480 
Rpl23a IPI00461456 P62751 8.08 0.04263 3.17 0.47740 
Rpl29 IPI00849550 P47915 8.08 0.11067 3.45 0.60516 
Ddx21 IPI00652987 Q3TVJ3 8.08 0.02534 0.82 0.86489 
Dkc1 IPI00113635 Q9ESX5 8.05 0.41005 4.09 0.77786 
Snrnp40 IPI00461621 Q6PE01 8.04 0.00099 2.72 0.04662 
Rps9 IPI00420726 Q6ZWN5 8.03 0.02496 3.45 0.31544 
Arf6 IPI00221616 P62331 8.02 0.00295 8.97 0.00263 
Rps26 IPI00377441 P62855 8.00 0.32031 3.32 0.79211 
Zfp593 IPI00321357 Q9DB42 7.98 0.09775 6.87 0.20443 
Myl6 IPI00848866 Q60605-2 7.96 0.17703 5.79 0.42270 
Snrpb2 IPI00132576 Q9CQI7 7.91 0.12605 2.49 0.74578 
Pc4 IPI00225633 P11031 7.90 0.09009 6.72 0.19610 
Rpl18 IPI00555113 P35980 7.90 0.02496 3.09 0.36530 
Rpl10 IPI00915054 Q3THJ6 7.90 0.04915 4.01 0.34408 
Tcof1 IPI00115660 O08784 7.90 0.01551 6.39 0.04137 
Cktsf1b1 IPI00280124 O70326 7.89 0.12475 4.62 0.47081 
Polr2a IPI00136207 P08775 7.84 0.21507 5.51 0.49208 
Kiaa1823 IPI00137302 Q9D4J7-1 7.83 0.16863 1.99 0.82373 
Pop101 IPI00605037 Q52KI8-1 7.82 0.04211 5.67 0.14834 
Rpl17 IPI00626233 Q9CPR4 7.82 0.08481 3.17 0.58358 
Cpsf5;Nudt21 IPI00132473 Q9CQF3 7.76 0.12254 0.53 0.95010 
Unnamed protein IPI00551538 
 
7.76 0.50606 7.69 0.60516 
Ncl;Nuc IPI00317794 P09405 7.74 0.01442 3.47 0.21179 
Gnl2 IPI00938448 B1ASC3 7.73 0.00778 5.98 0.02335 
Utp15 IPI00226889 Q8C7V3 7.73 0.23076 4.36 0.61525 
Nol5a;Nop56 IPI00318048 Q9D6Z1 7.68 0.26632 1.95 0.86489 
Rras2 IPI00323822 P62071 7.67 0.03240 7.41 0.04844 
Rpl28 IPI00222547 P41105 7.65 0.07488 3.32 0.51477 
Usp39 IPI00457815 Q3TIX9 7.62 0.06119 3.33 0.47935 
Ascc3l1 IPI00420329 Q69ZZ3 7.60 0.02431 1.56 0.69025 
Ckap4 IPI00223047 Q8BMK4 7.58 0.02980 -0.74 0.88076 
Rpl27 IPI00122421 P61358 7.57 0.22205 3.39 0.70631 
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Ctcf IPI00320741 Q61164 7.57 0.00649 0.63 0.82673 
Rps6 IPI00113655 P62754 7.56 0.26632 1.61 0.89697 
Rps16 IPI00469918 Q5CZY9 7.56 0.25721 4.89 0.58824 
Rig;Rps15 IPI00319231 P62843 7.53 0.54307 4.74 0.79211 
Dmap1;Mmtr IPI00317722 Q9JI44-1 7.50 0.27429 6.11 0.49036 
Rps15a IPI00230660 P62245 7.48 0.36126 4.99 0.65723 
C130057N11Rik IPI00828741 A2AU63 7.47 0.17581 2.74 0.74108 
Ddx31 IPI00421196 Q6NZQ2 7.44 0.01805 7.88 0.01913 
Tceb2 IPI00131224 P62869 7.44 0.00287 8.43 0.00248 
L27a;mCG_2315 IPI00626628 Q9CQ16 7.42 0.00278 3.97 0.02633 
Prp31;Prpf31 IPI00331424 Q8CCF0-1 7.40 0.15286 5.22 0.39704 
Rfc2;mCG_16697 IPI00124744 Q9WUK4 7.39 0.06119 6.89 0.10285 
Ing5 IPI00114689 Q9D8Y8-1 7.39 0.06775 -0.55 0.93854 
Kiaa0017;Sf3b3 IPI00122011 Q921M3-1 7.38 0.10315 1.72 0.80679 
Sf3b2;mCG_19856 IPI00349401 Q3UAI4 7.35 0.01381 4.41 0.09561 
D7Wsu180e IPI00133532 Q9CRA8 7.33 0.02496 5.82 0.07004 
Mrpl22 IPI00225318 Q8BU88 7.31 0.00341 7.55 0.00420 
Senp3;Smt3ip IPI00109326 Q9EP97 7.29 0.01952 5.59 0.06244 
Rps8;mCG_14435 IPI00466820 P62242 7.26 0.04619 3.31 0.39287 
Adprt2;Adprtl2 IPI00131935 O88554 7.23 0.02496 -1.21 0.75624 
Arbp;Rplp0 IPI00314950 P14869 7.23 0.26312 4.45 0.61110 
Rbm28 IPI00229472 Q8CGC6 7.22 0.07626 6.28 0.15460 
Csnk2a1 IPI00408176 Q61177 7.20 0.27269 6.34 0.44546 
Rps23 IPI00131357 P62267 7.20 0.10496 2.44 0.69415 
Rfc5 IPI00132481 Q9D0F6 7.18 0.37655 1.03 0.94248 
Pes;Pes1 IPI00620167 Q9EQ61 7.18 0.01172 7.92 0.01176 
Hnrnpr;Hnrpr IPI00128441 Q3U8W9 7.16 0.14181 2.69 0.69652 
Rps17;mCG_15301 IPI00755495 P63276 7.15 0.03758 5.93 0.09263 
Sr140 IPI00830853 Q6NV83-1 7.14 0.02496 5.82 0.06537 
Btf3;mCG_114993 IPI00515257 Q64152-1 7.13 0.08481 7.26 0.11281 
Arl10c;Arl8b IPI00133218 Q9CQW2 7.13 0.00766 7.82 0.00845 
Rrp1b;mKIAA0179 IPI00130246 Q91YK2 7.13 0.00406 -1.59 0.36122 
Ilf3 IPI00130591 Q9Z1X4-3 7.12 0.09816 8.80 0.07429 
Rpl26 IPI00132460 P61255 7.12 0.06622 3.09 0.49463 
Rrbp1 IPI00121149 Q99PL5-1 7.07 0.00820 7.11 0.01160 
Rps7;Rps7A IPI00136984 P62082 7.06 0.10604 3.52 0.51477 
Rpl9;mCG_10266 IPI00122413 P51410 7.03 0.06119 3.57 0.38950 
4933421E11Rik IPI00228791 Q8CDD9-1 7.00 0.03552 0.42 0.93854 
Cdc73 IPI00170345 Q8JZM7 6.98 0.00508 6.53 0.00879 
Hdgfrp2 IPI00116442 Q3UMU9-3 6.97 0.22299 6.38 0.35138 
Exosc8;Rrp43 IPI00109639 Q9D753 6.95 0.29741 4.79 0.59351 
Hdac2;Yy1bp IPI00137668 P70288 6.95 0.26632 2.63 0.78610 
Ddx10 IPI00896604 Q80Y44 6.92 0.00665 4.63 0.03238 
Gatad2b IPI00128615 Q8VHR5-1 6.89 0.01579 9.92 0.00688 
Kiaa0007;Wdr43 IPI00938465 Q6ZQL4 6.88 0.06119 1.90 0.69442 
Thrap3;Trap150 IPI00556768 Q569Z6 6.88 0.35734 5.46 0.57917 
Appendix 
 83 
Sfrs2;Pr264 IPI00474430 Q8C671 6.87 0.48861 5.54 0.68061 
Eftud2 IPI00649950 A2AH85 6.86 0.18326 2.30 0.76616 
Aly;Ref1;Refbp1 IPI00114407 O08583-1 6.86 0.56008 1.53 0.93854 
mCG_132913 IPI00225634 Q6ZWZ6 6.86 0.31242 6.27 0.47034 
Fam98a IPI00457756 Q3TJZ6 6.85 0.14181 6.44 0.22985 
Glut1;Glut-1 IPI00308691 P17809 6.84 0.20510 -0.11 0.98307 
Rpl7 IPI00311236 P14148 6.84 0.58313 6.39 0.69652 
Eif2a;Eif2s1 IPI00474446 Q6ZWX6 6.83 0.51967 3.75 0.81552 
Aporp1;Arp1 IPI00117234 P43135 6.81 0.00295 8.41 0.00167 
Lyar IPI00113232 Q08288 6.81 0.42882 1.69 0.92156 
Zc3hav1 IPI00136572 Q3UPF5-1 6.81 0.02122 6.62 0.03035 
Rnu1a-1;Snrpa IPI00122350 Q62189 6.80 0.42055 5.66 0.61239 
Rps4;Rps4x IPI00331092 P62702 6.80 0.12475 3.57 0.51477 
Rps14;rps14 IPI00322562 P62264 6.80 0.02595 3.25 0.26517 
Top2;Top-2 IPI00122223 Q01320 6.79 0.10505 3.34 0.51477 
Rpl21 IPI00315548 Q4VA28 6.78 0.02552 3.28 0.25898 
Rps11 IPI00117569 Q9DB79 6.77 0.04467 3.31 0.34762 
Baz2a;Kiaa0314 IPI00944144 Q91YE5-3 6.75 0.16309 3.97 0.51477 
Ilf2;Nf45 IPI00318550 Q9CXY6 6.73 0.50733 2.90 0.85691 
Aatf;Che1;Trb IPI00123565 Q9JKX4-1 6.72 0.02662 3.69 0.20660 
Cpsf6 IPI00421085 Q6NVF9 6.69 0.15846 1.04 0.90436 
Rpl23 IPI00139780 P62830 6.68 0.55008 4.94 0.75504 
Gpx4;GPx4 IPI00660262 O70325-2 6.67 0.00790 6.13 0.01372 
Mybbp1a IPI00331361 Q7TPV4 6.64 0.03240 2.49 0.45568 
Pgam5 IPI00848970 Q8BX10-1 6.63 0.25692 6.07 0.39287 
Rpl12 IPI00849793 P35979 6.62 0.02264 3.36 0.21252 
Pop1 IPI00169797 Q8K205 6.61 0.09223 6.78 0.12037 
Exosc7 IPI00387489 Q4VBW5 6.61 0.05135 5.98 0.09561 
Stau1 IPI00749596 A2A5S3 6.59 0.00470 6.52 0.00688 
Rps5 IPI00944141 Q91V55 6.55 0.04838 4.05 0.23514 
Rpl7a;Surf3 IPI00330363 P12970 6.53 0.27094 2.09 0.82596 
Impnb;Kpnb1 IPI00323881 P70168 6.50 0.40686 3.46 0.76077 
Eif2s2 IPI00116302 Q99L45 6.50 0.26632 5.45 0.46509 
Gatad2a IPI00625995 Q8CHY6 6.47 0.21847 6.82 0.26611 
Nle1 IPI00930808 B1ARD5 6.47 0.05507 5.99 0.09561 
Nxf1;Tap IPI00115588 Q99JX7 6.45 0.42010 2.50 0.84416 
Ant2;Slc25a5 IPI00127841 P51881 6.43 0.36541 11.38 0.16183 
G22p2;Xrcc5 IPI00321154 P27641 6.43 0.03240 6.88 0.03681 
Unnamed protein IPI00849047 
 
6.42 0.04938 6.63 0.06244 
Tex10 IPI00458057 Q3URQ0 6.42 0.13522 5.88 0.23169 
Rnasep2;Rpp30 IPI00134346 O88796 6.39 0.05251 6.33 0.07369 
Pdlim2 IPI00153375 Q8R1G6 6.38 0.00143 6.35 0.00162 
Gltscr2 IPI00122471 Q3USL3 6.37 0.03263 6.40 0.04460 
Ki-67;Mki67 IPI00124959 Q61769 6.36 0.04467 -4.19 0.20024 
Rpl4;mCG_12784 IPI00111412 Q9D8E6 6.32 0.30451 2.00 0.84416 
Cebpb IPI00116613 P28033 6.29 0.01271 4.63 0.04728 
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Big;Big3 IPI00139957 P61965 6.28 0.07719 1.74 0.72038 
Anc1;Ant1 IPI00115564 P48962 6.27 0.26632 4.99 0.49133 
Rpl7l1 IPI00111695 Q9D8M4 6.27 0.43184 2.36 0.85713 
Nfib IPI00130129 P97863-1 6.22 0.03466 6.30 0.04662 
Rps3 IPI00134599 P62908 6.22 0.07061 3.24 0.39704 
Cdc46;Mcm5 IPI00309398 P49718 6.21 0.16728 0.25 0.97349 
Cbfb;Pebp2b IPI00229487 Q08024-2 6.18 0.02167 6.56 0.02231 
Cbp80;Ncbp1 IPI00458056 Q3UYV9 6.15 0.01607 5.53 0.03080 
Chd3 IPI00675483 B1AR17 6.11 0.00820 7.01 0.00842 
Ppp1a;Ppp1ca IPI00130185 P62137 6.10 0.44103 1.79 0.90033 
Nolc1 IPI00720058 Q6ZQK6 6.09 0.03504 4.46 0.12390 
Rpl6;mCG_16023 IPI00313222 P47911 6.08 0.58160 5.41 0.71242 
Ssb;Ss-b IPI00134300 P32067 6.06 0.46912 3.70 0.75672 
Sfrs2ip IPI00874991 Q6ZPE9 6.05 0.01551 6.37 0.01620 
Kiaa0731;Larp IPI00929786 Q6ZQ58-1 6.04 0.06449 7.43 0.04662 
Rps13 IPI00125901 P62301 6.03 0.08090 3.36 0.39002 
Ngd;Ngdn IPI00119201 Q9DB96 6.03 0.33024 4.17 0.61336 
Rps3a;mCG_1128 IPI00331345 P97351 6.02 0.69084 3.20 0.88241 
Chaf1b IPI00132770 Q9D0N7 5.98 0.10042 7.02 0.09077 
Snrpd2;mCG_4862 IPI00119220 P62317 5.97 0.42010 5.05 0.60516 
Baz1a;Cbp146 IPI00461396 O88379 5.93 0.03281 1.59 0.61525 
Rab5c IPI00404579 Q8C266 5.92 0.05829 0.89 0.85070 
Np95;Uhrf1 IPI00130200 Q8VDF2 5.90 0.54269 4.35 0.75118 
Sfrs4 IPI00606760 A2A837 5.86 0.03154 6.06 0.03904 
Msy1;Msy-1 IPI00120886 P62960 5.86 0.35608 2.28 0.82156 
Jund;Jun-d IPI00126223 P15066 5.84 0.03504 6.24 0.03974 
Cdc5l;Kiaa0432 IPI00284444 Q6A068 5.81 0.24776 4.32 0.50407 
Gins1;Psf1 IPI00122249 Q9CZ15 5.80 0.03130 7.42 0.01802 
Gzf1;Zfp336 IPI00756220 Q4VBD9 5.76 0.00875 5.67 0.01255 
Fxr2;Fxr2h IPI00652944 Q3TA75 5.76 0.41331 4.99 0.58744 
Gpsn2;Tecr IPI00875068 Q52L67 5.73 0.01629 6.52 0.01373 
Slit3;Slit1 IPI00667854 B1ATW4 5.73 0.00231 5.68 0.00263 
Hnrnpu;Hnrpu IPI00458583 Q8VEK3 5.72 0.02496 2.45 0.31811 
Prp8;Prpf8 IPI00121596 Q99PV0 5.70 0.05848 2.81 0.39547 
Chd4 IPI00857771 Q5DTP7 5.69 0.04977 1.87 0.59164 
Haf;Sart1 IPI00323674 Q9Z315 5.69 0.21653 3.93 0.50371 
Fmr1;Fmr-1 IPI00227005 P35922-3 5.67 0.59095 2.88 0.85713 
Kiaa0162 IPI00454050 Q62383 5.67 0.03240 5.98 0.03793 
Mphosph6 IPI00134044 Q9D1Q1 5.64 0.05838 5.81 0.07355 
Slit2 IPI00128415 Q9R1B9 5.63 0.00649 5.35 0.01015 
D10Wsu52e IPI00116850 Q99LF4 5.62 0.10937 11.34 0.01718 
Rab18 IPI00116770 P35293 5.62 0.36932 4.75 0.55231 
Rpl11;mCG_5487 IPI00331461 Q9CXW4 5.59 0.02294 3.00 0.19155 
Ddx17 IPI00653307 Q3U741 5.57 0.11208 0.58 0.92734 
Nup205 IPI00929832 B0LAE1 5.56 0.06119 3.97 0.21094 
Unnamed protein IPI00330406 
 
5.51 0.08107 3.76 0.27622 
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Kpna2;Rch1 IPI00124973 P52293 5.47 0.48889 0.47 0.97171 
Matr3 IPI00453826 Q8K310 5.46 0.46262 4.28 0.67423 
Rps25 IPI00137735 P62852 5.45 0.07061 3.15 0.33817 
Arf5 IPI00221615 P84084 5.43 0.05445 5.61 0.06819 
Fbp11;Fnbp3 IPI00284213 Q9R1C7-1 5.43 0.17563 2.72 0.61284 
Hrs;Sfrs5 IPI00314709 O35326 5.42 0.70030 7.17 0.66583 
Ipo7;Ranbp7 IPI00331444 Q9EPL8 5.40 0.09816 6.57 0.07752 
Nipbl IPI00421052 Q6KCD5-1 5.38 0.29787 1.19 0.90033 
Snrpd1 IPI00322749 P62315 5.31 0.68866 5.22 0.75504 
U2af2;U2af65 IPI00113746 P26369 5.30 0.21827 3.54 0.51477 
Kif20a;Rab6kifl IPI00123947 P97329 5.30 0.08398 -5.25 0.12037 
Tubb2c;Tubb2c1 IPI00169463 P68372 5.30 0.57140 6.08 0.59351 
Sfrs9 IPI00132340 Q9D0B0 5.29 0.29319 2.57 0.73740 
Sin3a;mKIAA4126 IPI00117932 Q60520-1 5.21 0.03263 5.81 0.03241 
Hnrnpa0;Hnrpa0 IPI00109813 Q9CX86 5.17 0.59637 1.94 0.90612 
Aprin;As3 IPI00845638 Q4VA53-3 5.16 0.16228 5.93 0.16326 
Srfbp1 IPI00395196 Q9CZ91 5.16 0.42010 1.08 0.92734 
Wdr18 IPI00136252 Q4VBE8 5.15 0.47078 -2.43 0.82373 
Hnrnpc;Hnrpc IPI00223443 Q9Z204-2 5.08 0.10654 1.58 0.73231 
FAM120A IPI00830478 Q6A0A9 5.05 0.03466 5.11 0.04654 
Eif2s3x IPI00230415 Q9Z0N1 5.04 0.55141 2.81 0.82367 
Kiaa1341;Mef2 IPI00226891 Q8C854-4 5.04 0.42871 2.99 0.75188 
Rpl3;mCG_11520 IPI00755309 Q3T9U9 5.03 0.50877 1.66 0.89906 
Ddx15;Deah9 IPI00128818 O35286 5.01 0.21827 4.27 0.38369 
Fbl IPI00119581 P35550 5.00 0.72286 1.51 0.94248 
Wdr61;mCG_9684 IPI00112320 Q9ERF3 4.99 0.42640 3.66 0.67391 
Wiz IPI00263016 O88286-1 4.98 0.15013 0.28 0.96448 
Pcbp1 IPI00128904 P60335 4.88 0.41215 3.15 0.70631 
Alg4;Kiaa0185 IPI00551454 Q6NS46 4.87 0.25432 -0.79 0.92617 
Supt5h IPI00656221 O55201-1 4.87 0.22322 2.01 0.74059 
Mcm3;Mcmd IPI00108338 P25206 4.84 0.27094 5.44 0.29432 
Pak1ip1 IPI00120790 Q9DCE5 4.81 0.43038 2.51 0.78637 
Smn;Snrpn IPI00128699 P63163 4.80 0.12428 2.27 0.57922 
Mem3;Vps35 IPI00111181 Q9EQH3 4.80 0.03077 5.01 0.03681 
Srcap IPI00620743 Q8BKT0 4.79 0.42055 5.37 0.47034 
Nol14;Nop14 IPI00353010 Q8R3N1 4.78 0.23026 2.58 0.63695 
Ddx5;Tnz2 IPI00420363 Q61656 4.77 0.24082 3.22 0.53949 
Lamr1;P40-8;Rps IPI00123604 P14206 4.73 0.09223 2.42 0.47887 
Rps18;mCG_23000 IPI00317590 P62270 4.72 0.10051 3.22 0.32317 
Lig3;mCG_8187 IPI00124272 P97386-1 4.71 0.09329 5.04 0.10960 
Eef1d;mCG_22130 IPI00944009 P57776-3 4.70 0.50884 -0.34 0.97611 
Epb7.2;Epb72 IPI00323748 P54116 4.69 0.21847 4.81 0.27744 
Ppih IPI00848926 Q9D868-2 4.67 0.57140 1.37 0.92734 
Tuba1;Tuba1a IPI00110753 P68369 4.66 0.58037 1.01 0.94248 
Rps10 IPI00112448 P63325 4.66 0.20056 2.95 0.52428 
Slc25a1 IPI00276926 Q3TDH6 4.66 0.52588 4.95 0.59314 
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Ddx9;Dhx9 IPI00339468 O70133-2 4.49 0.49433 1.64 0.87635 
Hdac1 IPI00114232 O09106 4.44 0.09770 4.25 0.15511 
Mrps26 IPI00108194 Q80ZS3 4.42 0.12307 3.50 0.28132 
Crp1;Csrp IPI00123891 P97315 4.39 0.27429 -0.43 0.95157 
Chd2 IPI00845761 Q3V0V7 4.34 0.19811 0.39 0.94583 
Hnrnpm;Hnrpm IPI00132443 Q9D0E1-1 4.31 0.49585 2.96 0.74401 
Polr2e IPI00337955 Q80UW8 4.26 0.04619 1.65 0.49133 
Snrp1c;Snrpc IPI00123376 Q62241 4.26 0.37374 1.66 0.82373 
Csnk1a1 IPI00330729 Q8BK63-1 4.26 0.01201 4.32 0.01480 
Rpl30;mCG_20799 IPI00222549 P62889 4.23 0.38719 2.55 0.71841 
Rbbp5 IPI00226384 Q3TBL4 4.22 0.07052 2.52 0.32084 
Trim56 IPI00453527 Q80VI1 4.21 0.00412 3.20 0.01255 
Toe1;mCG_19662 IPI00134747 Q9D2E2-1 4.16 0.29612 5.19 0.26517 
C5orf24 homolog IPI00330644 Q80X32 4.08 0.13233 1.97 0.58033 
Puf60 IPI00652919 Q3UEB3-1 4.07 0.68102 6.81 0.51947 
Rbmx2 IPI00261255 Q8R0F5 4.01 0.39406 0.71 0.93441 
Plrg1 IPI00331172 Q922V4 4.00 0.36459 5.50 0.27507 
Xrcc1;Xrcc-1 IPI00118139 Q60596 3.98 0.36226 1.97 0.75830 
Hnrnpf;Hnrpf IPI00226073 Q9Z2X1-1 3.92 0.47078 2.14 0.79252 
Ehmt2 IPI00756765 A2CG77 3.91 0.11903 0.12 0.97611 
Dimt1;Dimt1l IPI00132415 Q9D0D4 3.89 0.69084 -0.14 0.98509 
A170;Sqstm1 IPI00133374 Q64337-1 3.88 0.34273 -2.14 0.71870 
Sap155 IPI00623284 Q99NB9 3.88 0.58399 2.18 0.83647 
Alg2;Pdcd6 IPI00121736 P12815 3.86 0.68547 3.48 0.77581 
Mecp2 IPI00775806 Q9Z2D6-2 3.83 0.38340 3.46 0.52656 
Sfrs3 IPI00129323 P84104-1 3.78 0.05789 2.95 0.16060 
Ruvbl2 IPI00123557 Q9WTM5 3.78 0.29428 3.22 0.48403 
Hmgts;Tfam IPI00112822 P40630-1 3.77 0.72175 2.39 0.86613 
Afg3l2 IPI00170357 Q8JZQ2 3.74 0.10319 2.73 0.29213 
Drim;Utp20 IPI00850851 Q5XG71 3.72 0.00668 2.92 0.01847 
Chd1;Chd-1 IPI00107999 P40201 3.70 0.00406 3.95 0.00456 
Snrpd3 IPI00119224 P62320 3.69 0.26703 1.87 0.69652 
Mphosph8 IPI00121617 A6H600 3.68 0.52274 0.83 0.93441 
Cdk9;mCG_18574 IPI00114953 Q99J95-1 3.62 0.42871 2.37 0.71870 
Dnaja2 IPI00136251 Q9QYJ0 3.61 0.72197 2.91 0.82855 
Actg;Actg1 IPI00874482 P63260 3.57 0.72723 4.47 0.71962 
Adnp2;Kiaa0863 IPI00875894 Q8CHC8 3.55 0.04155 4.80 0.02066 
Pairbp1;Serbp1 IPI00471476 Q9CY58-2 3.55 0.75116 1.80 0.92156 
Rent1;Upf1 IPI00420949 Q9EPU0-1 3.55 0.43068 2.84 0.63715 
Fip1l1 IPI00881462 Q9D824-1 3.55 0.66647 2.22 0.84702 
Ddb1 IPI00316740 Q3U1J4 3.49 0.26632 -2.03 0.63695 
Bclaf1 IPI00620639 Q05C67 3.48 0.77755 0.75 0.96867 
MNCb-1706 IPI00283671 Q9CY57-1 3.48 0.71676 0.71 0.96168 
mCG_12245;Rbbp4 IPI00828412 A2A875 3.46 0.35786 2.56 0.60753 
Cbx;Cbx1 IPI00129466 P83917 3.41 0.12307 0.14 0.97171 
Dnajc9 IPI00128268 Q91WN1 3.41 0.71949 0.39 0.97611 
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Spin;Spin1 IPI00653709 Q3UWM7 3.38 0.41982 0.44 0.94836 
Cbx3;mCG_119115 IPI00677454 Q32P00 3.35 0.12586 0.25 0.94620 
Fxr1;Fxr1h IPI00122521 Q61584-1 3.34 0.77755 -1.09 0.94583 
Rbm14;p16 IPI00404707 Q8C2Q3-1 3.34 0.60846 2.90 0.74401 
Skp1;Skp1a IPI00331163 Q9WTX5 3.28 0.67209 2.49 0.81407 
Prkcbp1 IPI00108978 A2A484 3.28 0.27696 4.15 0.24266 
Mcm6;Mcmd6 IPI00123881 P97311 3.21 0.47078 0.86 0.92156 
Ddx48;Eif4a3 IPI00126716 Q91VC3 3.20 0.72286 1.13 0.93784 
Cpsf100;Cpsf2 IPI00314302 O35218 3.20 0.22252 1.18 0.76756 
Ruvbl1;Tip49 IPI00133985 P60122 3.18 0.46938 2.69 0.64054 
Rbap46;Rbbp7 IPI00122698 Q60973 3.14 0.39812 1.55 0.77800 
Nap1l1 IPI00929813 P28656 3.07 0.69652 2.61 0.80679 
Kiaa0324 IPI00785240 Q8BTI8-1 3.01 0.35776 1.44 0.76616 
H2a.x;H2afx IPI00230264 P27661 2.97 0.66894 4.11 0.60516 
Cenpl IPI00830718 Q14A61 2.92 0.52274 2.18 0.73740 
Kiaa1707;Senp7 IPI00403228 Q8BUH8 2.89 0.54661 -1.20 0.86995 
Rfc3 IPI00665571 Q8R323 2.87 0.84512 1.49 0.93854 
Orc4l IPI00752477 Q8BN98 2.78 0.75497 -3.85 0.71242 
Actl6;Actl6a IPI00323660 Q9Z2N8 2.77 0.37415 1.45 0.75504 
Gapd;Gapdh IPI00874964 P16858 2.75 #VALUE! 0.74 0.27845 
Kiaa1584;Suhw3 IPI00169658 Q6P3Y5-1 2.70 0.72175 -3.30 0.71962 
Rnu3ip2;Rrp9 IPI00128256 Q91WM3 2.68 0.71670 0.70 0.94583 
Kpna3;Qip2 IPI00230429 O35344 2.64 0.74740 0.75 0.94677 
Cdc47;Mcm7 IPI00126396 Q61881 2.63 0.27269 1.17 0.75118 
Pno1 IPI00131909 Q9CPS7 2.60 0.74740 0.30 0.97734 
Baf170;Smarcc2 IPI00459742 Q6PDG5-1 2.59 0.10148 1.12 0.58744 
Hnrnph1;Hnrph1 IPI00224729 Q8C2Q7 2.59 0.67620 1.17 0.90272 
D1Pas1-rs2;Ddx3 IPI00230035 Q62167 2.58 0.40717 0.70 0.89889 
Kiaa0650;Smchd1 IPI00137433 Q6P5D8 2.57 0.40894 0.25 0.96317 
Nsa2;Tinp1 IPI00468437 Q9CR47 2.49 0.58015 0.45 0.94836 
Prp19;Prpf19 IPI00222760 Q99KP6-2 2.46 0.80291 2.67 0.82596 
Hbo1;Myst2 IPI00515403 Q5SVQ0-1 2.44 0.24062 -1.43 0.61120 
Tim50;Timm50 IPI00111045 Q9D880 2.44 0.67570 0.13 0.98192 
Baf190a;Brg1 IPI00460668 Q3TUD7 2.40 0.54559 0.66 0.92734 
Ccdc55 IPI00345960 Q5NCR9 2.39 0.00002 3.90 0.00000 
Sdpr IPI00135660 Q63918 2.38 0.77755 1.48 0.90501 
Cbx5;Hp1a IPI00123755 Q61686 2.36 0.37655 -0.52 0.92156 
Hsc70;Hsc73 IPI00323357 P63017 2.27 0.35118 1.31 0.70631 
Fug1;Rangap1 IPI00467338 P46061 2.24 0.42010 -1.80 0.61840 
Col8a1 IPI00399464 Q00780 2.21 0.78852 2.65 0.79211 
Fn1 IPI00352163 B7ZNJ1 2.20 0.75750 2.94 0.73343 
Orc1;Orc1l IPI00130290 Q9Z1N2 2.18 0.68126 -6.25 0.23169 
Nsd3;Whsc1l1 IPI00663331 Q6P2L6-1 2.16 0.77217 0.98 0.92868 
Brd1;mKIAA4191 IPI00330331 Q571F6 2.10 0.62300 -0.12 0.98192 
cbp37;Gtl6 IPI00623570 O88380 2.06 0.66408 -2.89 0.59314 
Tpx2 IPI00420481 A2APB8 2.02 0.84263 -6.81 0.47740 
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Ase1;Cd3eap IPI00169700 Q76KJ5 1.99 0.75111 1.69 0.83647 
Tra2a IPI00377298 Q6PFR5 1.98 0.86442 -0.24 0.98192 
Cdw5;Wdr82_ IPI00221414 Q8BFQ4 1.97 0.59637 -0.10 0.98192 
Hbxap;Rsf1 IPI00122845 Q3UJ04 1.97 0.22256 0.67 0.79211 
Kpna4;Qip1 IPI00129792 O35343 1.93 0.81499 3.02 0.74887 
Grp78;Hspa5 IPI00319992 P20029 1.92 0.42871 1.28 0.71242 
Fn1 IPI00652813 B9EHT6 1.92 0.23324 1.33 0.51477 
Hnrnpl IPI00620362 Q8R081 1.90 0.59637 0.45 0.93854 
Poldip3 IPI00229721 Q8BG81 1.90 0.58327 -3.98 0.27845 
Unnamed protein IPI00118632 
 
1.84 0.68163 0.47 0.94415 
Prss3 IPI00130391 B9EJ35 1.83 0.86688 1.10 0.93854 
Erh;mCG_7617 IPI00403589 P84089 1.82 0.75256 -0.65 0.93854 
H1f1;Hist1h1a IPI00228616 P43275 1.82 0.64893 -0.44 0.94248 
Smarca5;Snf2h IPI00396739 Q91ZW3 1.80 0.38340 -1.44 0.59320 
Ddx5 IPI00648763 B1ARB9 1.78 0.79981 0.92 0.92734 
Baz1b;Wbscr9 IPI00923656 Q9Z277-1 1.78 0.42871 -2.47 0.34425 
U2af1;mCG_14259 IPI00318548 Q9D883 1.76 0.91103 1.82 0.92734 
Cnbp;Cnbp1 IPI00454151 P53996-3 1.73 0.51967 -0.73 0.86318 
Hmga1 IPI00954313 Q3TE85 1.63 0.62738 0.51 0.92734 
D4Cole1e;Nmnat IPI00109667 Q9EPA7 1.62 0.45784 2.11 0.41933 
mKIAA0138;Safb2 IPI00605227 Q6A0C0 1.62 0.77217 -2.93 0.62410 
Smc1a IPI00944715 A0JLM6 1.60 0.82764 0.53 0.95994 
Rrp15 IPI00458958 Q9CYX7 1.59 0.89696 -0.57 0.97154 
Cct1;Ccta IPI00459493 P11983-1 1.53 0.84956 -0.17 0.98192 
Cct8;Cctq IPI00469268 P42932 1.53 0.67543 0.91 0.85963 
Insrr;mCG_3075 IPI00896646 B2RQC5 1.49 0.08398 -0.02 0.98307 
Jun IPI00121829 P05627 1.47 0.74719 0.31 0.96317 
Copb2 IPI00115097 O55029 1.45 0.37796 0.49 0.85691 
Cse1l;Xpo2 IPI00112414 Q9ERK4 1.42 0.82301 2.42 0.73478 
Nrap IPI00135182 Q80XB4-1 1.40 0.79335 2.06 0.74401 
Adprp;Adprt IPI00112473 P11103-1 1.35 0.77217 -3.11 0.51115 
Hmga2 IPI00752993 Q6NSP9 1.34 0.73919 -2.21 0.61509 
Gnas;Gnas1 IPI00416906 Q6R0H7-1 1.32 0.74182 1.93 0.67439 
Men1;mCG_5034 IPI00918121 O88559 1.27 0.87420 -6.14 0.36388 
Ledgf;Psip1 IPI00115257 Q99JF8-1 1.26 0.86442 -1.72 0.84416 
H1f3;Hist1h1d IPI00331597 P43277 1.23 0.88704 1.11 0.92303 
Hmga1;Hmgi IPI00624711 P17095-1 1.23 0.77755 1.32 0.81407 
Tubb5 IPI00117352 P99024 1.21 0.90369 2.04 0.85691 
Ddx51 IPI00396728 Q6P9R1 1.20 0.72286 -0.01 0.99682 
Lmn1;Lmna IPI00620256 P48678-1 1.16 0.72197 -1.11 0.79211 
Grp75;Hsp74 IPI00133903 P38647 1.16 0.82439 1.39 0.82373 
Orc5;Orc5l IPI00125261 Q9WUV0 1.15 0.91061 -5.92 0.49977 
Hmga2 IPI00331612 P52927 1.14 0.66524 0.41 0.92734 
Rrp7a IPI00133594 Q9D1C9 1.13 0.89602 -2.10 0.82172 
Hnrnpa2b1 IPI00853914 O88569-1 1.10 0.89367 -1.54 0.86613 
Aros;Rps19bp1 IPI00226227 Q8C6B9 1.06 0.80745 2.94 0.49036 
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Gnai3 IPI00338854 Q9DC51 1.04 0.76088 0.06 0.98307 
Hist1h2bk IPI00875277 Q8CGP1 1.03 0.92860 -1.00 0.94468 
Rab21 IPI00337980 P35282 0.97 0.84670 1.70 0.75624 
Ddx52;Rok1 IPI00336965 Q8K301 0.96 0.51525 -0.20 0.93854 
Atp5h IPI00230507 Q9DCX2 0.96 0.87323 -1.08 0.88076 
H3.1-221 IPI00553538 P68433 0.96 0.95503 0.74 0.97154 
D2Wsu81e IPI00224127 Q3UHX9-1 0.93 0.79335 0.55 0.92156 
H3.3a;H3.3b IPI00785343 P84244 0.89 0.96150 2.36 0.92303 
DinG;Ring1b IPI00133880 Q9CQJ4 0.85 0.94907 -0.96 0.94836 
mCG_10339;Tmpo IPI00896574 B2RUB9 0.84 0.92743 -3.29 0.69966 
Mafg;mCG_2153 IPI00755238 O54790 0.80 0.92743 -5.04 0.47922 
Ftsj3 IPI00119632 Q9DBE9 0.77 0.60568 1.45 0.36882 
Naa40;Nat11 IPI00137271 Q8VE10-1 0.77 0.77755 -7.56 0.01435 
Hmga1;Hmgi IPI00314240 P17095-2 0.73 0.88704 -0.15 0.97957 
D1Wsu40e;Imp4 IPI00395166 Q8VHZ7 0.71 0.89131 0.22 0.97171 
H1f2;Hist1h1c IPI00223713 P15864 0.69 0.82439 -0.34 0.93854 
Aldh18a1 IPI00944043 Q3TWN8 0.68 0.92743 -3.14 0.63567 
Msi2;Msi2h IPI00120924 Q920Q6-1 0.63 0.92860 1.54 0.84416 
Sdha IPI00230351 Q8K2B3 0.61 0.92860 2.97 0.64043 
Mtf2;Pcl2 IPI00467892 Q02395-1 0.57 0.86113 -4.46 0.10233 
D1Ertd578e IPI00222122 Q8BIG4 0.53 0.92743 -2.55 0.63148 
;Smarcd2;Baf60b IPI00649685 B1ARJ6 0.52 0.95823 -2.53 0.81243 
Hp1bp3 IPI00896020 Q3TEA8-2 0.52 0.89359 -0.46 0.92734 
Pb1;Pbrm1;Baf18 IPI00461676 Q8R134 0.51 0.91106 4.52 0.21167 
H1f0;H1fv IPI00467914 P10922 0.50 0.91226 -1.50 0.75188 
Ran;Rasl2-8 IPI00134621 P62827 0.50 0.90329 -2.47 0.47935 
Kiaa1403;Rpap1 IPI00377618 Q80TE0-1 0.49 0.96263 -1.11 0.93441 
Kiaa1709;Nat10 IPI00276866 Q8K224 0.47 0.91335 -1.02 0.82721 
Ccdc137 IPI00153212 Q8R0K4 0.44 0.91335 -1.26 0.76228 
H1f4;Hist1h1e IPI00223714 P43274 0.39 0.92860 0.37 0.94415 
Hmgn2 IPI00918033 B7ZCQ2 0.38 0.97767 -1.69 0.92303 
Imp9;Ipo9 IPI00130158 Q91YE6 0.36 0.96150 0.28 0.97331 
Hist1h2af IPI00229543 Q8CGP5 0.28 0.95503 -1.18 0.81243 
Kcnc3 IPI00467430 Q63959-1 0.26 0.98236 -0.22 0.98192 
Hmg14 IPI00338745 P18608 0.23 0.98412 -3.28 0.85109 
Ark2;Aurkb IPI00268655 O70126 0.23 0.94414 -7.45 0.01495 
H1f5 IPI00230133 P43276 0.23 0.96718 -0.90 0.90218 
Kiaa0938 REV__IPI001 Q80TN7 0.19 0.95503 -8.45 0.01160 
Sap18 IPI00915480 O55128 0.12 0.98672 -1.20 0.92734 
Orc3;Orc3l IPI00311034 Q9JK30-1 0.12 0.98297 -7.35 0.17057 
Cdc21;Mcm4 IPI00117016 P49717 0.09 0.96122 -1.04 0.47740 
H2afy2;H2afy3 IPI00652934 Q8CCK0 0.08 0.98236 0.84 0.86489 
D11Ertd530e IPI00396676 Q80U70 0.02 0.99279 -2.53 0.38950 
H2afv IPI00555055 Q3THW5 0.00 0.99908 -0.90 0.51330 
Hmgn3 IPI00120653 Q9DCB1-1 -0.03 0.99279 -1.60 0.76228 
H3.2 IPI00282848 P84228 -0.08 0.89423 -0.23 0.69025 
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Rnps1;RNPS1 IPI00122227 Q62150 -0.09 0.98412 -0.34 0.96867 
Ahnak2 IPI00850843 Q3UUE0 -0.10 0.96471 1.45 0.44451 
Bp75;Brd7 IPI00133099 O88665 -0.10 0.97922 -1.94 0.56475 
H4-12 IPI00623776 P62806 -0.12 0.92743 -0.14 0.92734 
Sfrs10 IPI00139259 P62996-1 -0.13 0.98814 -0.93 0.95761 
Ptrf IPI00117689 O54724 -0.18 0.98410 1.26 0.92734 
Rrp8 IPI00653834 Q3U4B0 -0.18 0.97922 -5.54 0.30595 
Arglu1 IPI00652831 Q3UL36-1 -0.20 0.94414 -1.03 0.71870 
Hist2h2ab IPI00623951 Q64522 -0.25 0.96571 -12.24 0.02638 
Scaf1;Sfrs19 IPI00344430 Q5U4C3-1 -0.27 0.92743 -4.55 0.05920 
Ctdspl2 IPI00454047 Q8BG15-1 -0.34 0.96571 -7.75 0.23784 
Rps27a IPI00470152 P62983 -0.39 0.92844 -0.47 0.92960 
Plec1 IPI00626385 Q9QXS1-2 -0.41 0.93800 -0.91 0.88258 
Hist1h2bh IPI00876550 Q64478 -0.54 0.14181 -0.32 0.47935 
Parp1 IPI00139168 Q3TF18 -0.54 0.71934 -3.26 0.03941 
Phc2 IPI00894922 B2KFW6 -0.55 0.94414 -1.89 0.82338 
Phgdh IPI00225961 Q61753 -0.63 0.95503 -3.13 0.78091 
Ndrp;Phip IPI00311490 Q8VDD9 -0.63 0.92860 -4.88 0.42149 
Dek IPI00227720 Q7TNV0 -0.64 0.70862 6.64 0.00645 
Fus;Taf15 IPI00117063 P56959 -0.73 0.79145 0.07 0.98192 
Sf3a1 IPI00408796 Q8K4Z5 -0.86 0.93833 -0.49 0.97171 
Coq6 IPI00222526 Q8R1S0 -0.88 0.82439 -8.22 0.03457 
Fosl2;Fra2 IPI00338178 P47930 -0.94 0.92860 -2.33 0.85070 
Hist2h2aa1 IPI00330000 Q6GSS7 -0.99 0.51286 -1.02 0.59164 
Orc2;Orc2l IPI00121509 Q60862 -1.06 0.82439 -8.29 0.05898 
Rbmxrt;Hnrnpg IPI00663587 Q91VM5 -1.13 0.89367 -3.21 0.69166 
Actbl2 IPI00221528 Q8BFZ3 -1.16 0.94414 2.11 0.92303 
Smu1 IPI00331342 Q3UKJ7-1 -1.28 0.72175 -2.67 0.47935 
Numa1 IPI00263048 Q3TH77 -1.46 0.88071 -2.02 0.85691 
Csrp2;Dlp1 IPI00470178 P97314 -1.49 0.74292 8.36 0.06413 
Cct4;Cctd IPI00116277 P80315 -1.51 0.75256 -1.79 0.75624 
Kiaa0170;Mdc1 IPI00753701 Q5PSV9 -1.56 0.89367 -2.19 0.86489 
Kif22 IPI00116757 Q3V300 -1.59 0.64893 -7.09 0.05761 
Nfix IPI00331515 Q5CZY4 -1.67 0.85785 -0.32 0.97621 
Sfpq IPI00129430 Q8VIJ6 -1.73 0.86688 -3.49 0.75504 
Baf47;Ini1 IPI00129145 Q9Z0H3-1 -1.76 0.84956 -7.14 0.38267 
Lrwd1 IPI00225459 Q8BUI3-1 -2.20 0.80190 -6.41 0.45568 
Wdr76 IPI00856332 A6PWY4-1 -2.22 0.84198 -1.18 0.93854 
Nono IPI00320016 Q99K48-1 -2.24 0.89934 -4.43 0.82048 
Rcc1;Chc1 IPI00123762 Q3U6D2 -2.60 0.58930 -3.80 0.49629 
Bmi1;Bmi-1 IPI00114786 P25916 -3.31 0.10817 0.59 0.85963 
Pab2;Pabp2 IPI00136169 Q8CCS6-1 -3.47 0.69084 -0.03 0.99578 
Kif20b;Mphosph1 IPI00874587 Q80WE4-1 -3.78 0.07783 0.03 0.98509 
Lap2 IPI00320399 Q61029-1 -4.20 0.03552 1.18 0.61120 
H2afy IPI00378480 Q9QZQ8-1 -4.46 0.00375 -0.81 0.47740 
Cbx8;Pc3 IPI00135606 Q9QXV1 -5.31 0.54780 -6.14 0.57713 
Appendix 
 91 
Cav;Cav1 IPI00117829 P49817-1 -5.37 0.10465 -2.58 0.52656 
Ppp2r1a IPI00310091 Q76MZ3 -5.49 0.09816 1.53 0.75214 
H2afy IPI00137852 Q9QZQ8-2 -5.58 0.65424 -8.19 0.56221 
Tpm4 IPI00421223 Q6IRU2 -5.63 0.09223 -7.79 0.04844 
Suv39h1 IPI00261633 O54864-2 -6.36 0.33417 -5.49 0.51330 
Khdrbs1 IPI00458765 Q60749 -6.99 0.16309 -3.62 0.58824 
Ahctf1;Elys IPI00122594 Q8CJF7 -7.07 0.14321 -10.07 0.07576 
Unnamed protein IPI00850532 
 
-7.36 0.00983 -8.05 0.01088 
Baf57;Smarce1 IPI00119892 O54941 -7.42 0.02826 -7.32 0.03974 
Kiaa1470;Rcc2 IPI00222509 Q8BK67 -7.50 0.07736 -6.75 0.14259 
Enx1h;Ezh2 IPI00468525 Q61188-1 -7.86 0.00228 -10.26 0.00095 
Eed IPI00900431 Q921E6-2 -8.45 0.00254 -7.37 0.00494 
Lpl IPI00319188 P11152 -9.75 0.03803 -2.97 0.58824 
Rgs18 IPI00121020 Q99PG4 -13.61 0.01919 -5.20 0.33318 
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